TWI774046B - Use of solanum muricatum fermented liquid for preparing a composition for promoting skin anti-aging ability, promoting anti-glycation ability, reducing melanin content, increasing skin moisturization, reducing skin texture, reducing skin wrinkles, reducing skin redness and/or reducing fat - Google Patents
Use of solanum muricatum fermented liquid for preparing a composition for promoting skin anti-aging ability, promoting anti-glycation ability, reducing melanin content, increasing skin moisturization, reducing skin texture, reducing skin wrinkles, reducing skin redness and/or reducing fat Download PDFInfo
- Publication number
- TWI774046B TWI774046B TW109129405A TW109129405A TWI774046B TW I774046 B TWI774046 B TW I774046B TW 109129405 A TW109129405 A TW 109129405A TW 109129405 A TW109129405 A TW 109129405A TW I774046 B TWI774046 B TW I774046B
- Authority
- TW
- Taiwan
- Prior art keywords
- cantaloupe
- juice
- gene
- tomato
- skin
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Obesity (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medical Informatics (AREA)
- Toxicology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
一種香瓜茄發酵汁液的用途,其用於製備一組合物。此組合物具有下列一種或多種功能:提升穀胱甘肽合成、抑制醣化終產物形成、提升抗老相關基因、抑制黑色素生成、提升保濕相關基因分泌、抑制脂肪累積、促進脂肪分解、減少受體的體脂肪以及改善肌膚狀況。並且,此香瓜茄發酵汁液是由一香瓜茄培養液與及複數菌種進行一發酵程序所得。 A use of cantaloupe tomato fermented juice for preparing a composition. The composition has one or more of the following functions: enhancing glutathione synthesis, inhibiting the formation of glycation end products, enhancing anti-aging related genes, inhibiting melanin production, enhancing moisturizing-related gene secretion, inhibiting fat accumulation, promoting lipolysis, reducing receptors body fat and improve skin condition. In addition, the cantaloupe and eggplant fermentation juice is obtained by performing a fermentation process with a cantaloupe and eggplant culture medium and a plurality of bacterial species.
Description
本發明是關於香瓜茄發酵汁液,特別是關於香瓜茄發酵汁液用於製備改善肌膚狀況及/或減脂組合物的用途。 The present invention relates to cantaloupe tomato fermented juice, in particular to the use of cantaloupe tomato fermented juice for preparing skin condition and/or fat-reducing compositions.
自有機及天然的飲食概念興起後,生技公司及食品業者積極投入關於天然植物的相關產品之研發。為使植物相關產品對身體健康助益有科學驗證的基礎,植物的活性成分分析及功效評估成為產品開發的重點項目。 Since the rise of the concept of organic and natural diets, biotechnology companies and food companies have been actively investing in the research and development of natural plant-related products. In order to make plant-related products have a scientifically proven basis for their health benefits, active ingredient analysis and efficacy evaluation of plants have become key items in product development.
香瓜茄(Pepino Dulce,學名為Solanum muricatum),又名人參果,是茄科茄屬的多年生草本植物。香瓜茄原產於南美洲地區,近年來成為研究開發的天然植物之一。 Pepino Dulce (scientific name Solanum muricatum), also known as ginseng fruit, is a perennial herb of the nightshade family Solanaceae. Cantaloupe is native to South America and has become one of the natural plants researched and developed in recent years.
在一實施例中,一種香瓜茄發酵汁液的用途,其是用於製備 用以提升抗氧化能力的組合物,其中,香瓜茄發酵汁液是由一香瓜茄培養液與及複數菌種進行一發酵程序所得,香瓜茄培養液包括香瓜茄汁及水,香瓜茄汁與水的比例為1:2-5。相對於香瓜茄培養液,複數菌種包括0.01%-0.5%的酵母菌、0.01%-0.25%的乳酸菌及1%-15%的醋酸菌。 In one embodiment, a kind of purposes of cantaloupe tomato fermented juice, it is for preparing The composition for improving antioxidant capacity, wherein, the cantaloupe and eggplant fermentation juice is obtained by performing a fermentation procedure with a cantaloupe tomato culture medium and a plurality of bacterial species, and the cantaloupe tomato culture liquid comprises cantaloupe tomato juice and water, and cantaloupe tomato juice and water The ratio is 1:2-5. Compared with the cantaloupe and eggplant culture medium, the multiple strains include 0.01%-0.5% yeast, 0.01%-0.25% lactic acid bacteria and 1%-15% acetic acid bacteria.
在一實施例中,一種香瓜茄發酵汁液的用途,其是用於製備用於製備用以改善肌膚狀況的組合物。其中,香瓜茄發酵汁液是由一香瓜茄培養液與及複數菌種進行一發酵程序所得。香瓜茄培養液包括香瓜茄汁及水,香瓜茄與水的比例為1:2-5,相對於香瓜茄培養液,複數菌種包括0.01%-0.5%的酵母菌、0.01%-0.25%的乳酸菌及1%-15%的醋酸菌。 In one embodiment, the use of a cantaloupe tomato fermented juice is used to prepare a composition for improving skin condition. Wherein, the cantaloupe and eggplant fermentation juice is obtained by performing a fermentation procedure with a cantaloupe and eggplant culture medium and a plurality of bacterial species. The cantaloupe and eggplant culture solution includes cantaloupe tomato juice and water, and the ratio of cantaloupe and eggplant to water is 1:2-5. Compared with the cantaloupe and eggplant culture solution, the multiple strains include 0.01%-0.5% yeast, 0.01%-0.25% Lactic acid bacteria and 1%-15% acetic acid bacteria.
在一實施例中,一種香瓜茄發酵汁液的用途,其是用於製備用以減少脂肪的組合物。其中,香瓜茄發酵汁液是由一香瓜茄培養液與及複數菌種進行一發酵程序所得。香瓜茄培養液包括香瓜茄汁及水,且香瓜茄與水的比例為1:2-5。相對於香瓜茄培養液,複數菌種包括0.01%-0.5%的酵母菌、0.01%-0.25%的乳酸菌及1%-15%的醋酸菌。 In one embodiment, a use of cantaloupe fermented juice for preparing a composition for reducing fat. Wherein, the cantaloupe and eggplant fermentation juice is obtained by performing a fermentation procedure with a cantaloupe and eggplant culture medium and a plurality of bacterial species. The cantaloupe and eggplant culture solution includes cantaloupe tomato juice and water, and the ratio of cantaloupe and eggplant to water is 1:2-5. Compared with the cantaloupe and eggplant culture medium, the multiple strains include 0.01%-0.5% yeast, 0.01%-0.25% lactic acid bacteria and 1%-15% acetic acid bacteria.
在又一實施例中,香瓜茄發酵汁液提升抗氧化能力為提升總和抗氧化能力(Total Anti-oxidative Capacity)、降低過氧化產物MDA(Malondialdehyde)、提升穀胱甘肽或其組合。 In another embodiment, the antioxidant capacity of the cantaloupe tomato fermented juice is increased by increasing the total antioxidant capacity (Total Anti-oxidative Capacity), reducing the peroxidation product MDA (Malondialdehyde), increasing glutathione, or a combination thereof.
在又一實施例中,香瓜茄發酵汁液改善肌膚狀況為提升肌膚抗老能力、提升抗醣化能力、降低黑色素含量、提升肌膚保濕、減少肌膚紋理、減少肌膚皺紋、減少肌膚泛紅或其組合。 In yet another embodiment, the fermented juice of cantaloupe to improve skin condition is to improve skin anti-aging ability, improve anti-glycation ability, reduce melanin content, improve skin moisturization, reduce skin texture, reduce skin wrinkles, reduce skin redness or a combination thereof.
在又一實施例中,香瓜茄發酵汁液提升肌膚抗老能力為調控CCT5基因、FOXO基因、MRPS5基因、Pink1基因或UBL5基因。 In yet another embodiment, the fermented juice of cantaloupe tomato to enhance skin anti-aging ability is to regulate CCT5 gene, FOXO gene, MRPS5 gene, Pink1 gene or UBL5 gene.
在又一實施例中,香瓜茄發酵汁液提升肌膚保濕為調控HAS2基因或KRT1基因。 In yet another embodiment, the fermented juice of cantaloupe tomato to enhance skin moisturizing is the regulation of HAS2 gene or KRT1 gene.
在又一實施例中,香瓜茄發酵汁液減少脂肪為抑制脂肪累積、促進脂肪分解或其組合。 In yet another embodiment, the cantaloupe fermented juice reduces fat by inhibiting fat accumulation, promoting lipolysis, or a combination thereof.
在又一實施例中,香瓜茄發酵汁液是透過發酵程序所製備,其中發酵程序包括添加該酵母菌至該香瓜茄培養液內;將該香瓜茄培養液與該酵母菌進行發酵1日至3日以形成一第一初發酵汁液,其中該酵母菌較佳為Saccharomyces cerevisiae;添加該乳酸菌至該第一初發酵汁液內;將該第一初發酵汁液與該乳酸菌進行發酵1日至5日以形成一第二初發酵汁液,其中該乳酸菌較佳為Streptococcus thermophilus;添加該醋酸菌至該第二初發酵汁液內;將該第二初發酵汁液與該醋酸菌進行發酵3日至10日以形成一第三初發酵汁液,其中該醋酸菌較佳為Acetobacter aceti;以及過濾該第三初發酵汁液所得到。 In yet another embodiment, the cantaloupe and eggplant fermentation juice is prepared through a fermentation process, wherein the fermentation process includes adding the yeast to the cantaloupe tomato culture solution; fermenting the cantaloupe and eggplant culture solution with the yeast for 1 to 3 days to form a first initial fermentation juice, wherein the yeast is preferably Saccharomyces cerevisiae; adding the lactic acid bacteria to the first initial fermentation juice; fermenting the first initial fermentation juice and the lactic acid bacteria for 1 to 5 days forming a second primary fermentation juice, wherein the lactic acid bacteria is preferably Streptococcus thermophilus; adding the acetic acid bacteria into the second primary fermentation juice; fermenting the second primary fermentation juice and the acetic acid bacteria for 3 to 10 days to form a third primary fermentation juice, wherein the acetic acid bacteria is preferably Acetobacter aceti; and filtering the third primary fermentation juice.
在又一實施例中,香瓜茄發酵汁液的pH值為4.0±1.0,且香瓜茄發酵汁液的糖度為40±2。 In yet another embodiment, the pH of the cantaloupe fermented juice is 4.0±1.0, and the sugar content of the cantaloupe fermented juice is 40±2.
在又一實施例中,香瓜茄發酵汁液的多酚含量為88ppm。 In yet another embodiment, the polyphenol content of the cantaloupe tomato fermented juice is 88 ppm.
綜上所述,根據本發明任一實施例的香瓜茄發酵汁液,其可製備改善肌膚狀況及/或減脂的組合物。換言之,前述之組合物具有下列一種或多種功能:提升穀胱甘肽合成、抑制醣化終產物形成、提升抗老相關基因、抑制黑色素生成、提升保濕相關基因分泌、抑制脂肪累積、促進脂肪分解、減少受體的體脂肪以及改善肌膚狀況。 To sum up, according to the fermented juice of cantaloupe tomato according to any embodiment of the present invention, a composition for improving skin condition and/or reducing fat can be prepared. In other words, the aforementioned composition has one or more of the following functions: enhancing glutathione synthesis, inhibiting the formation of glycation end products, enhancing anti-aging-related genes, inhibiting melanin production, enhancing moisturizing-related gene secretion, inhibiting fat accumulation, promoting lipolysis, Reduces body fat in receptors and improves skin condition.
以下將進一步說明本發明的實施方式,下述所列舉的實施例 係用以闡明本發明,並非用以限定本發明之範圍,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可做些許更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 Embodiments of the present invention will be further described below, with the following examples It is used to illustrate the present invention, not to limit the scope of the present invention. Anyone who is familiar with this technique can make some changes and modifications without departing from the spirit and scope of the present invention. Therefore, the protection scope of the present invention should be regarded as The scope of the attached patent application shall prevail.
圖1是繪示香瓜茄培養液(發酵前)與香瓜茄發酵汁液(發酵後)的總多酚含量的變化之長條圖。 FIG. 1 is a bar graph showing the change of the total polyphenol content of the cantaloupe and tomato culture broth (before fermentation) and the cantaloupe fermented juice (after fermentation).
圖2是繪示各組別的相對穀胱甘肽含量之長條圖。 Figure 2 is a bar graph showing the relative glutathione content of each group.
圖3是繪示各組別的相對醣化終產物形成量之長條圖。 Figure 3 is a bar graph showing the relative amounts of glycation end products formed for each group.
圖4是繪示各組別的相對抗老基因表現量之長條圖。 FIG. 4 is a bar graph showing the relative expression levels of anti-aging genes in each group.
圖5是繪示各組別的相對黑色素含量之長條圖。 Figure 5 is a bar graph showing the relative melanin content of each group.
圖6是繪示各組別的相對保濕基因表現量之長條圖。 FIG. 6 is a bar graph showing the relative moisturizing gene expression of each group.
圖7是繪示各組別的抑制脂肪堆積效果之長條圖。 FIG. 7 is a bar graph showing the effect of inhibiting fat accumulation in each group.
圖8是繪示各組別的促進脂肪分解之長條圖。 FIG. 8 is a bar graph showing the promotion of lipolysis for each group.
圖9是繪示各組別的相對燃脂基因表現量之長條圖。 Figure 9 is a bar graph showing the relative expression of fat-burning genes in each group.
圖10是繪示一示範例之香瓜茄發酵汁液使用前與使用後的體重的變化之長條圖。 FIG. 10 is a bar graph showing the change in body weight before and after use of the cantaloupe tomato fermented juice of an example.
圖11是繪示一示範例之香瓜茄發酵汁液使用前與使用後的全身體脂率的變化之長條圖。 FIG. 11 is a bar graph showing the change of the whole body fat percentage before and after use of the cantaloupe tomato fermented juice of an example.
圖12是繪示一示範例之香瓜茄發酵汁液使用前與使用後的軀幹體脂率的變化之長條圖。 FIG. 12 is a bar graph showing the change of the trunk body fat percentage before and after use of the cantaloupe tomato fermented juice of an example.
圖13是繪示一示範例之香瓜茄發酵汁液使用前與使用後的臀圍的變 化之長條圖。 FIG. 13 is a graph showing the change of hip circumference of the cantaloupe tomato fermented juice before and after use of an example. Transformed bar chart.
圖14是繪示一示範例之香瓜茄發酵汁液使用前與使用後的總合抗氧化能力的變化之長條圖。 Fig. 14 is a bar graph showing the change of the total antioxidant capacity of the fermented juice of cantaloupe and eggplant before and after use.
圖15是繪示一示範例之香瓜茄發酵汁液使用前與使用後的物過氧化產物MDA的變化之長條圖。 FIG. 15 is a bar graph showing the change of the peroxidation product MDA of the cantaloupe tomato fermented juice before and after use of an exemplary example.
圖16是繪示一示範例之香瓜茄發酵汁液使用前與使用後的相對肌膚紋理(粗糙度)的變化之長條圖。 FIG. 16 is a bar graph showing the change in relative skin texture (roughness) of the cantaloupe tomato fermented juice before and after use.
圖17是一示範例之香瓜茄發酵汁液使用前與使用後的相對肌膚皺紋的變化之長條圖。 Fig. 17 is a bar graph showing changes in relative skin wrinkles before and after use of the cantaloupe and eggplant fermented juice.
圖18是一示範例之香瓜茄發酵汁液使用前與使用後的相對肌膚泛紅(紅色素)的變化之長條圖。 FIG. 18 is a bar graph showing changes in relative skin redness (red pigment) before and after use of the cantaloupe and eggplant fermented juice of an example.
圖19是一示範例之香瓜茄發酵汁液使用前與使用後的相對肌膚含水量的變化之長條圖。 FIG. 19 is a bar graph showing the change of relative skin moisture content before and after use of the cantaloupe and eggplant fermented juice.
關於本文中所使用之濃度符號「%」通常是指重量百分濃度,而濃度符號「vol%」通常是指體積百分濃度。關於本文中所使用之「香瓜茄」通常是指香瓜茄果實。 The concentration symbol "%" as used herein generally refers to weight percent concentration, while the concentration symbol "vol%" generally refers to volume percent concentration. As used herein, "cantaloupe" generally refers to the fruit of cantaloupe.
關於本文中所使用之「香瓜茄培養液」、「香瓜茄水萃液」用語可交互使用,所指皆為香瓜茄汁與水混合均勻後的混合物。 The terms "cantaloupe and eggplant culture liquid" and "cantaloupe and eggplant water extract" used in this article can be used interchangeably, and both refer to the mixture of cantaloupe tomato juice and water evenly mixed.
依據本發明,有關微生物發酵反應的操作程序與參數條件等是落在熟習此項技術之人士的專業素養與例行技術範疇內。 According to the present invention, the operation procedures and parameter conditions related to the microbial fermentation reaction fall within the professional quality and routine technical scope of those who are familiar with the technology.
在一些實施例中,香瓜茄發酵汁液是由香瓜茄培養液與及複 數菌種進行一發酵程序所得。其中,香瓜茄培養液包括香瓜茄及水。在香瓜茄培養液中,香瓜茄與水的比例為1:2-5。在發酵程序中,相對於香瓜茄培養液,此些菌種包括0.01%-0.5%的酵母菌、0.01%-0.25%的乳酸菌及1%-15%的醋酸菌。 In some embodiments, the cantaloupe and tomato fermented juice is composed of the cantaloupe and tomato culture broth and Obtained by performing a fermentation procedure with several strains. Wherein, the cantaloupe and eggplant culture solution includes cantaloupe and eggplant and water. In the cantaloupe medium, the ratio of cantaloupe to water is 1:2-5. In the fermentation process, these strains include 0.01%-0.5% yeast, 0.01%-0.25% lactic acid bacteria and 1%-15% acetic acid bacteria relative to the cantaloupe medium.
在一些實施例中,酵母菌可以是啤酒酵母(Saccharomyces cerevisiae)。在一些實施例中,乳酸菌可以是嗜熱鏈球菌(Streptococcus thermophilus)或植物乳桿菌。在一些實施例中,醋酸菌可以是乙酸醋酸菌(Acetobacter aceti)。 In some embodiments, the yeast may be Saccharomyces cerevisiae. In some embodiments, the lactic acid bacteria may be Streptococcus thermophilus or Lactobacillus plantarum. In some embodiments, the acetic acid bacteria can be Acetobacter aceti.
在一些實施例中,在發酵程序中,先添加0.01%-0.5%的酵母菌至香瓜茄培養液內,並將香瓜茄培養液與酵母菌進行發酵1日至3日以形成第一初發酵汁液。換言之,0.01%-0.5%的酵母菌與香瓜茄培養液混合成的第一混合液進行發酵1日至3日以形成第一初發酵汁液。在一些實施例中,第一混合液是在28℃-37℃下進行發酵。 In some embodiments, in the fermentation process, 0.01%-0.5% yeast is added to the cantaloupe tomato culture solution, and the cantaloupe tomato culture solution and yeast are fermented for 1 to 3 days to form the first primary fermentation juice. In other words, the first mixed liquid obtained by mixing 0.01%-0.5% of the yeast with the cantaloupe and eggplant culture liquid is fermented for 1 to 3 days to form the first initial fermentation juice. In some embodiments, the first mixed liquor is fermented at 28°C-37°C.
於第一初發酵汁液形成後,再添加0.01%-0.25%乳酸菌至第一初發酵汁液內,並將第一初發酵汁液與乳酸菌進行發酵1日至5日以形成第二初發酵汁液。換言之,0.01%-0.25%乳酸菌與第一初發酵汁液混合成的第二混合液進行發酵1日至5日以形成第二初發酵汁液。在一些實施例中,第二混合液是在28℃-37℃下進行發酵。 After the first primary fermentation juice is formed, 0.01%-0.25% lactic acid bacteria are added to the first primary fermentation juice, and the first primary fermentation juice and lactic acid bacteria are fermented for 1 to 5 days to form the second primary fermentation juice. In other words, the second mixed liquor obtained by mixing 0.01%-0.25% lactic acid bacteria and the first primary fermentation juice is fermented for 1 to 5 days to form the second primary fermentation juice. In some embodiments, the second mixed liquor is fermented at 28°C-37°C.
於第二初發酵汁液形成後,再添加1%-15%的醋酸菌至第二初發酵汁液內,並將第二初發酵汁液與醋酸菌進行發酵3日至10日以形成第三初發酵汁液。換言之,1%-15%的醋酸菌與第二初發酵汁液混合成的第三混合液進行發酵3日至10日以形成第三初發酵汁液。在一些實施例 中,第三混合液是在28℃-37℃下進行發酵。 After the second primary fermentation juice is formed, 1%-15% acetic acid bacteria are added to the second primary fermentation juice, and the second primary fermentation juice and acetic bacteria are fermented for 3 to 10 days to form the third primary fermentation juice. In other words, the third mixed liquor obtained by mixing 1%-15% of acetic bacteria and the second primary fermentation juice is fermented for 3 to 10 days to form the third primary fermentation juice. In some embodiments Among them, the third mixed liquor is fermented at 28°C-37°C.
於第三初發酵汁液形成後,過濾第三初發酵汁液以得到香瓜茄發酵汁液。在第一示範例中,第三初發酵汁液的過濾步驟包括以200目數至400目數的網孔的濾網過濾第三初發酵汁液。在第二示範例中,第三初發酵汁液的過濾步驟包括在40℃至70℃下減壓濃縮及以200目數至400目數的網孔的濾網過濾第三初發酵汁液。在第三示範例中,第三初發酵汁液的過濾步驟包括在40℃至70℃下減壓濃縮及以200目數至400目數的網孔的濾網過濾第三初發酵汁液以得到一發酵原液,以及調整發酵原液的糖度(Degrees Brix)以形成香瓜茄發酵汁液。 After the third primary fermentation juice is formed, the third primary fermentation juice is filtered to obtain the cantaloupe tomato fermented juice. In the first exemplary example, the filtering step of the third primary fermentation juice includes filtering the third primary fermentation juice with a filter screen having a mesh of 200 to 400 mesh. In the second exemplary example, the filtering step of the third primary fermentation juice includes concentrating under reduced pressure at 40°C to 70°C and filtering the third primary fermentation juice with a mesh of 200 to 400 mesh. In the third exemplary example, the filtering step of the third primary fermentation juice includes concentrating under reduced pressure at 40°C to 70°C and filtering the third primary fermentation juice with a mesh of 200 to 400 mesh to obtain a Fermentation stock solution, and adjusting the sugar content (Degrees Brix) of fermentation stock solution to form cantaloupe tomato fermented juice.
在一些實施例中,可透過添加55%-70%的賦形劑(excipient)來調整發酵原液的糖度。在一些實施例中,用以調整糖度的賦形劑可為異麥芽寡糖。 In some embodiments, the sugar content of the fermentation stock can be adjusted by adding 55%-70% excipients. In some embodiments, the excipient used to adjust the sugar content may be isomalt-oligosaccharide.
在一些實施例中,香瓜茄發酵汁液的pH值為3.7±1.0,且香瓜茄發酵汁液的糖度為40±2。 In some embodiments, the pH of the cantaloupe fermented juice is 3.7±1.0, and the sugar content of the cantaloupe fermented juice is 40±2.
在一些實施例中,香瓜茄發酵汁液的多酚含量為88ppm。 In some embodiments, the polyphenol content of the cantaloupe fermented juice is 88 ppm.
香瓜茄培養液是由香瓜茄汁與水以1:2-5的比例混合以得到。在第一示範例中,香瓜茄培養液是由選自於南美洲來源之香瓜茄果汁與水以1:2-5的比例混合以得到。在第二示範例中,香瓜茄培養液是由選自於祕魯Agro international business a&c sac公司之香瓜茄果汁與水以1:2-5的比例混合,再添加葡萄糖溶液將糖度調整為9以得到。在第三示範例中,香瓜茄培養液是由選自於祕魯Agro international business a&c sac公司之香瓜茄果汁與水以1:5的比例混合,再添加葡萄糖溶液將糖度 調整為9以得到。 The cantaloupe tomato culture solution is obtained by mixing cantaloupe tomato juice and water in a ratio of 1:2-5. In the first example, the cantaloupe culture solution is obtained by mixing cantaloupe juice selected from South American sources with water in a ratio of 1:2-5. In the second example, the cantaloupe and eggplant culture solution is mixed with water in a ratio of 1:2-5 from the cantaloupe and eggplant juice selected from Agro international business a&c sac company in Peru, and then a glucose solution is added to adjust the sugar content to 9 to obtain . In the third example, the cantaloupe and eggplant culture solution is a mixture of cantaloupe and eggplant juice selected from Peru Agro international business a&c sac company and water in a ratio of 1:5, and then a glucose solution is added to increase the sugar content Adjust to 9 to get.
在一些實施例中,原料混合液的滅菌程序可為將原料混合液在80℃至100℃下滅菌0.2小時至1小時,並將滅菌後的原料混合液冷卻至室溫(即25℃至30℃)以形成香瓜茄培養液。在一些實施例中,滅菌後的原料混合液可採取自然降溫的方式冷卻至室溫。 In some embodiments, the sterilization procedure of the raw material mixture may be sterilizing the raw material mixture at 80° C. to 100° C. for 0.2 hour to 1 hour, and cooling the sterilized raw material mixture to room temperature (ie, 25° C. to 30° C.). °C) to form a cantaloupe eggplant culture solution. In some embodiments, the sterilized raw material mixture can be cooled to room temperature by natural cooling.
在一些實施例中,香瓜茄發酵汁液具有改善肌膚狀況及/或減脂之作用。在一些示範例中,改善受體的肌膚狀況可為提升肌膚抗老能力、提升抗醣化能力、降低黑色素含量、提升肌膚保濕、減少肌膚紋理、減少肌膚皺紋、減少肌膚泛紅或其組合。在一些實施例中,香瓜茄發酵汁液能透過下列一種或多種細胞層面的作用來達成改善肌膚狀況及/或減脂之作用:提升穀胱甘肽合成、抑制醣化終產物形成、提升抗老相關基因、抑制黑色素生成、提升保濕相關基因分泌、抑制脂肪累積、促進脂肪分解、減少受體的體脂肪以及改善肌膚狀況。其中,受體可為人。 In some embodiments, the cantaloupe tomato fermented juice has the effect of improving skin condition and/or reducing fat. In some examples, improving the skin condition of the recipient can be improved skin anti-aging ability, improved anti-glycation ability, reduced melanin content, improved skin hydration, reduced skin texture, reduced skin wrinkles, reduced skin redness, or a combination thereof. In some embodiments, cantaloupe tomato fermented juice can improve skin condition and/or reduce fat through one or more of the following cellular-level actions: enhancing glutathione synthesis, inhibiting the formation of end-products of glycation, and enhancing anti-aging related Genes, inhibit melanin production, enhance moisturizing-related gene secretion, inhibit fat accumulation, promote lipolysis, reduce receptor body fat, and improve skin condition. Wherein, the receptor can be human.
在一些實施例中,香瓜茄發酵汁液能用於製備用以提升抗氧化能力的組合物,其中提升抗氧化能力可為提升總和抗氧化能力(Total Anti-oxidative Capacity)、降低過氧化產物MDA(Malondialdehyde)、提升穀胱甘肽或其組合。 In some embodiments, the cantaloupe tomato fermented juice can be used to prepare a composition for enhancing antioxidant capacity, wherein the enhancement of antioxidant capacity can be to increase the total antioxidant capacity (Total Anti-oxidative Capacity), reduce the peroxidation product MDA ( Malondialdehyde), boosting glutathione, or a combination thereof.
在一些實施例中,香瓜茄發酵汁液能用於製備用以改善肌膚狀況的組合物,其中改善肌膚狀況可為提升肌膚抗老能力、提升抗醣化能力、降低黑色素含量、提升肌膚保濕、減少肌膚紋理、減少肌膚皺紋、減少肌膚泛紅或其組合,其中提升肌膚抗老能力為調控CCT5基因、FOXO基因、MRPS5基因、Pink1基因或UBL5基因其中至少一項且提升肌膚保 濕為調控HAS2基因或KRT1基因其中至少一項。 In some embodiments, cantaloupe fermented juice can be used to prepare a composition for improving skin condition, wherein improving skin condition can be to improve skin anti-aging ability, improve anti-glycation ability, reduce melanin content, improve skin moisturization, reduce skin condition Texture, skin wrinkle reduction, skin redness reduction or a combination thereof, wherein improving skin anti-aging ability is regulating at least one of CCT5 gene, FOXO gene, MRPS5 gene, Pink1 gene or UBL5 gene and improving skin protection. Wet is to regulate at least one of HAS2 gene or KRT1 gene.
在一些實施例中,香瓜茄發酵汁液能用於製備用以減少脂肪的組合物,其中減少脂肪為抑制脂肪累積、促進脂肪分解或其組合。 In some embodiments, cantaloupe fermented juice can be used to prepare a composition for reducing fat, wherein reducing fat is inhibiting fat accumulation, promoting lipolysis, or a combination thereof.
在一些實施例中,前述之任一組合物可為醫藥品。換言之,此醫藥品包含有效含量的香瓜茄發酵汁液。 In some embodiments, any of the foregoing compositions can be a pharmaceutical. In other words, the medicinal product contains an effective content of fermented juice of cantaloupe and tomato.
在一些實施例中,前述之醫藥品可利用熟習此技藝者所詳知的技術而被製造成適合於經腸道地、非經腸道地(parenterally)、口服地、或局部地(topically)投藥劑型。 In some embodiments, the aforementioned pharmaceutical products can be manufactured for parenterally, parenterally, orally, or topically using techniques well known to those skilled in the art Dosage form.
在一些實施例中,經腸道或口服的投藥劑型可為,但不限於,錠劑(tablet)、片劑(troche)、口含錠(lozenge)、丸劑(pill)、膠囊(capsule)、分散性粉末(dispersible powder)或細顆粒(granule)、溶液、懸浮液(suspension)、乳劑(emulsion)、糖漿(syrup)、酏劑(elixir)、濃漿(slurry)或類似之物。在一些實施例中,非經腸道地或局部地投藥劑型可為,但不限於,注射品(injection)、無菌的粉末(sterile powder)、外部製劑(external preparation)或類似之物。在一些實施例中,注射品的投藥方式可為皮下注射(subcutaneous injection)、表皮內注射(intraepidermal injection)、皮內注射(intradermal injection)或病灶內注射(intralesional injection)。 In some embodiments, the dosage form for parenteral or oral administration can be, but is not limited to, a tablet, troche, lozenge, pill, capsule , dispersible powder or granule, solution, suspension, emulsion, syrup, elixir, slurry or the like. In some embodiments, the dosage form for parenteral or topical administration can be, but is not limited to, an injection, sterile powder, external preparation, or the like. In some embodiments, the injection can be administered by subcutaneous injection, intraepidermal injection, intradermal injection or intralesional injection.
在一些實施例中,前述之醫藥品可包含被廣泛地使用於藥物製造技術之醫藥上可接受的載劑(pharmaceutically acceptable carrier)。在一些實施例中,醫藥上可接受的載劑可為下列載劑中一種或多種:溶劑(solvent)、緩衝液(buffer)、乳化劑(emulsifier)、懸浮劑(suspending agent)、分解劑(decomposer)、崩解劑(disintegrating agent)、分散劑(dispersing agent)、黏結劑(binding agent)、賦形劑、安定劑(stabilizing agent)、螯合劑(chelating agent)、稀釋劑(diluent)、膠凝劑(gelling agent)、防腐劑(preservative)、潤濕劑(wetting agent)、潤滑劑(lubricant)、吸收延遲劑(absorption delaying agent)、脂質體(liposome)以及類似之物。關於選用之載劑的種類與數量是落在熟習此項技術之人士的專業素養與例行技術範疇內。在一些實施例中,作為醫藥上可接受的載劑的溶劑可為水、生理鹽水(normal saline)、磷酸鹽緩衝液(phosphate buffered saline,PBS)、或含有醇的水性溶液(alcohol containing aqueous solution)。 In some embodiments, the aforementioned pharmaceutical products may include pharmaceutically acceptable carriers that are widely used in pharmaceutical manufacturing techniques. In some embodiments, the pharmaceutically acceptable carrier can be one or more of the following carriers: solvent, buffer, emulsifier, suspending agent agent), decomposer, disintegrating agent, dispersing agent, binding agent, excipient, stabilizing agent, chelating agent, dilution Diluent, gelling agent, preservative, wetting agent, lubricant, absorption delaying agent, liposome and the like thing. Regarding the type and quantity of the carrier selected, it falls within the scope of the professional quality and routine skills of those who are familiar with the technology. In some embodiments, the solvent as a pharmaceutically acceptable carrier can be water, normal saline, phosphate buffered saline (PBS), or an alcohol containing aqueous solution ).
在一些實施例中,前述之任一組合物可為食用組合物。換言之,食用組合物包含特定含量的香瓜茄發酵汁液。在一些實施例中,前述之食用組合物可為食品產品或食品添加物(food additive)。在一些實施例中,食品產品可為但不限於:飲料(beverages)、發酵食品(fermented foods)、烘培產品(bakery products)、健康食品(health foods)或膳食補充品(dietary supplements)。 In some embodiments, any of the foregoing compositions may be edible compositions. In other words, the edible composition contains a specific amount of cantaloupe fermented juice. In some embodiments, the aforementioned edible composition may be a food product or a food additive. In some embodiments, the food products can be, but are not limited to, beverages, fermented foods, bakery products, health foods, or dietary supplements.
在一些實施例中,前述之食用組合物可以口服方式施予受體。其中,食用組合物的型態可為粉末、顆粒、溶液、膠體或膏體。 In some embodiments, the aforementioned edible compositions can be administered to a recipient orally. Wherein, the form of the edible composition can be powder, granule, solution, colloid or paste.
在一些實施例中,前述之任一組合物可為化妝品或保養品。換言之,化妝品或保養品包含特定含量的香瓜茄發酵汁液。 In some embodiments, any of the foregoing compositions can be a cosmetic or skin care product. In other words, cosmetics or skin care products contain a specific amount of cantaloupe tomato fermented juice.
在一些實施例中,前述之化妝品或保養品可為下列任一種型態:化妝水、凝膠、凍膜、泥膜、乳液、乳霜、唇膏、粉底、粉餅、蜜粉、 卸妝油、卸妝乳、洗面乳、沐浴乳、洗髮精、護髮乳、防曬乳、護手霜、指甲油、香水、精華液及面膜。在一些實施例中,前述之化妝品或保養品可視需要更包含外用品可接受成分。在一些實施例中,外用品可接受成分可例如為乳化劑、滲透促進劑、軟化劑、溶劑、賦型劑、抗氧化劑、或其組合。 In some embodiments, the aforementioned cosmetics or skin care products can be in any of the following forms: lotion, gel, jelly, mud film, lotion, cream, lipstick, foundation, powder, powder, Cleansing Oil, Cleansing Milk, Facial Cleanser, Body Wash, Shampoo, Conditioner, Sunscreen, Hand Cream, Nail Polish, Perfume, Serum and Mask. In some embodiments, the aforementioned cosmetics or skin care products may further include externally acceptable ingredients as needed. In some embodiments, topical acceptable ingredients may be, for example, emulsifiers, penetration enhancers, emollients, solvents, excipients, antioxidants, or combinations thereof.
實施例一:香瓜茄發酵汁液的製備 Embodiment 1: the preparation of cantaloupe tomato fermented juice
首先,將採購自秘魯,Agro international business a&c sac公司的香瓜茄汁(產品名Pepino Dulce,Nature Pulp,香瓜茄原產地為祕魯安地斯山脈)與水以1:5(即,香瓜茄汁為一倍重量,水為五倍重量)的比例混合均勻,再添加葡萄糖溶液將糖度調整為9.0,得到香瓜茄培養液。但本發明對於香瓜茄汁的來源並不限制,例如產地為南美洲之供應商為Peruvian Nature公司或Naike公司所提供的香瓜茄汁。 First, the cantaloupe tomato juice (product name Pepino Dulce, Nature Pulp, the origin of cantaloupe and tomato is the Peruvian Andes) purchased from Peru, Agro international business a&c sac company is mixed with water in a ratio of 1:5 (that is, the cantaloupe tomato juice is The ratio of one time weight and five times the weight of water) was mixed evenly, and then the glucose solution was added to adjust the sugar content to 9.0 to obtain the cantaloupe eggplant culture solution. However, the present invention does not limit the source of the cantaloupe tomato juice, for example, the cantaloupe tomato juice provided by Peruvian Nature or Naike Company from suppliers in South America.
接著,於香瓜茄培養液中殖入0.1%啤酒酵母(Saccharomyces cerevisiae)(購自食品工業發展研究所生物資源保存及研究中心(BCRC),寄存編號BCRC20271)並在約30℃下發酵1天,以得到第一初發酵汁液。接著,於第一初發酵汁液中殖入0.05%嗜熱鏈球菌(Streptococcus thermophilus)(購自BCRC,寄存編號BCRC910636)並在約30℃下發酵1天,以得到第二初發酵汁液。最後,於第二初發酵汁液中殖入10%乙酸醋酸菌(Acetobacter aceti)(購自BCRC,寄存編號BCRC11688)並在約30℃下發酵5天,以得到第三初發酵汁液。 Then, 0.1% brewer's yeast (Saccharomyces cerevisiae) (purchased from the Biological Resource Conservation and Research Center (BCRC) of the Institute of Food Industry Development, accession number BCRC20271) was propagated into the cantaloupe eggplant culture solution and fermented at about 30°C for 1 day, to obtain the first primary fermentation juice. Next, 0.05% Streptococcus thermophilus (purchased from BCRC, accession number BCRC910636) was propagated into the first primary fermentation juice and fermented at about 30° C. for 1 day to obtain a second primary fermentation juice. Finally, 10% Acetobacter aceti (purchased from BCRC, accession number BCRC11688) was propagated in the second primary fermentation juice and fermented at about 30°C for 5 days to obtain the third primary fermentation juice.
再將第三初發酵汁液在約60℃下進行減壓濃縮並以目數200的網孔的濾網過濾,以得到發酵原液。最後,添加60%異麥芽寡糖至 發酵原液後在約100℃下滅菌2小時,以得到香瓜茄發酵汁液。 The third primary fermentation juice is then concentrated under reduced pressure at about 60° C. and filtered through a mesh filter with a mesh number of 200 to obtain a fermentation stock solution. Finally, add 60% isomalt oligosaccharide to After fermenting the stock solution, it is sterilized at about 100° C. for 2 hours to obtain the cantaloupe tomato fermented juice.
於此,分別對香瓜茄培養液、發酵原液以及香瓜茄發酵汁液進行糖度檢測。其中,香瓜茄原料混合液的糖度約為9.0,發酵原液的糖度約為4.0,以及香瓜茄發酵汁液的糖度約為40。 Here, the sugar content of the cantaloupe and tomato culture liquid, the fermentation stock solution and the cantaloupe tomato fermented juice are detected respectively. Among them, the sugar content of the cantaloupe and eggplant raw material mixture is about 9.0, the sugar content of the fermentation stock solution is about 4.0, and the sugar content of the cantaloupe and eggplant fermentation juice is about 40.
實施例二:香瓜茄水萃液(無發酵)的製備 Embodiment 2: the preparation of cantaloupe eggplant water extract (without fermentation)
將採購自秘魯,Agro international business a&c sac公司(產品名Pepino Dulce,Nature Pulp,香瓜茄原產地為祕魯安地斯山脈)的香瓜茄汁與水以1:5的比例混合均勻,再添加葡萄糖溶液將糖度調整為9,得到香瓜茄水萃液,其pH值為6.3。 Mix the cantaloupe tomato juice purchased from Peru, Agro international business a&c sac company (product name Pepino Dulce, Nature Pulp, cantaloupe tomato from the Peruvian Andes) and water in a ratio of 1:5, then add glucose solution The sugar content was adjusted to 9, and the water extract of cantaloupe and eggplant was obtained, and its pH value was 6.3.
實施例三:總多酚含量測試 Embodiment 3: total polyphenol content test
秤取10.0mg的沒食子酸(Gallic acid)置於10mL容量瓶中,然後以水(H2O)定量至10mL,以得到沒食子酸的儲備溶液(stock solution)。將沒食子酸的儲備溶液稀釋10倍,即100μL沒食子酸的儲備溶液加900μL的水,以得到100μg/mL沒食子酸的初始溶液(即含1000ppm的沒食子酸)。然後,依據下表一配置0μg/mL、20μg/mL、40μg/mL、60μg/mL、80μg/mL、及100μg/mL之沒食子酸的標準溶液,並分別取100μL之各濃度的標準溶液至玻璃試管中。加入500μL之福林酚試劑(Folin-Ciocalteu's phenol reagent,購自Merck)至各玻璃試管內與標準溶液混合均勻並靜置3分鐘後,再加入400μL之7.5%碳酸鈉混合均勻後反應30分鐘以得到標準反應溶液。取200μL之標準反應溶液至96孔板中,並測量其在750nm下之吸光值,以獲得標準曲線。 10.0 mg of gallic acid was weighed into a 10 mL volumetric flask, and then quantified to 10 mL with water (H 2 O) to obtain a stock solution of gallic acid. The stock solution of gallic acid was diluted 10-fold, ie, 100 μL of the stock solution of gallic acid plus 900 μL of water, to obtain an initial solution of 100 μg/mL gallic acid (ie, containing 1000 ppm of gallic acid). Then, prepare standard solutions of gallic acid of 0 μg/mL, 20 μg/mL, 40 μg/mL, 60 μg/mL, 80 μg/mL, and 100 μg/mL according to Table 1, and take 100 μL of the standard solutions of each concentration. into a glass test tube. Add 500 μL of Folin-Ciocalteu's phenol reagent (purchased from Merck) to each glass test tube and mix it with the standard solution and let it stand for 3 minutes, then add 400 μL of 7.5% sodium carbonate, mix well, and react for 30 minutes. A standard reaction solution was obtained. Take 200 μL of the standard reaction solution into a 96-well plate, and measure its absorbance at 750 nm to obtain a standard curve.
表一
將實驗組的測試樣品(即實施例一的香瓜茄發酵汁液)及對照組的測試樣品(即實施例二的香瓜茄水萃液)分別以水稀釋10倍。將各樣本取100mL到玻璃試管中。接著,加入500μL之福林酚試劑至玻璃試管中與樣本混合均勻並靜置3分鐘後,再加入400μL之7.5%碳酸鈉混合均勻後反應30分鐘以得到待測反應溶液。將裝有待測反應溶液的玻璃試管進行震盪以確保無氣泡後,取200μL之待測反應溶液至96孔板中,並測量待測反應溶液於750nm下之吸光值。 The test samples of the experimental group (ie, the fermented juice of cantaloupe and eggplant in Example 1) and the test sample of the control group (ie, the water extract of cantaloupe and eggplant in Example 2) were diluted 10 times with water, respectively. 100 mL of each sample was taken into a glass test tube. Next, add 500 μL of Folin phenol reagent to the glass test tube and mix with the sample evenly and let it stand for 3 minutes, then add 400 μL of 7.5% sodium carbonate, mix well, and react for 30 minutes to obtain the reaction solution to be tested. After shaking the glass test tube containing the reaction solution to be tested to ensure no air bubbles, take 200 μL of the reaction solution to be tested into a 96-well plate, and measure the absorbance of the reaction solution to be tested at 750 nm.
接著,各樣本對應的待測反應溶液的吸光值先除以樣本的糖度,再利用標準曲線以內插法換算成總多酚含量。於此,可得到香瓜茄水萃液的總多酚含量為27ppm及香瓜茄發酵汁液的總多酚含量為88ppm,如圖1所示。由此可知,香瓜茄透過微生物發酵後,可增加總多酚含量3.2倍。即,相對於香瓜茄水萃液,香瓜茄發酵汁液能提升抗氧化活性。 Next, the absorbance value of the reaction solution to be tested corresponding to each sample is firstly divided by the sugar content of the sample, and then converted into the total polyphenol content by the interpolation method of the standard curve. Here, the total polyphenol content of the water extract of cantaloupe tomato was 27 ppm and the total polyphenol content of the cantaloupe tomato fermented juice was 88 ppm, as shown in FIG. 1 . It can be seen that the total polyphenol content of cantaloupe can be increased by 3.2 times after microbial fermentation. That is, compared with the water extract of cantaloupe and tomato, the fermented juice of cantaloupe and tomato can enhance the antioxidant activity.
實施例四:評估細胞抗氧化功效-穀胱甘肽含量檢測 Example 4: Assessing Cellular Antioxidant Efficacy - Detection of Glutathione Content
A.實驗材料 A. Experimental materials
1.細胞株:人類周邊血單核球細胞(human peripheral blood mononuclear cell,hPBMC)。 1. Cell line: human peripheral blood mononuclear cell (human peripheral blood mononuclear cell, hPBMC).
2.培養基:X-VIVO10培養基(購自Lonza,型號04-380Q) 2. Medium: X-VIVO10 medium (purchased from Lonza, model 04-380Q)
3.GSH檢測試劑(購自abcam,型號Ab112132)。 3. GSH detection reagent (purchased from abcam, model Ab112132).
4.香瓜茄水萃液:此實驗中所使用的香瓜茄水萃液是透過如上實施例二所獲得。 4. Water extract of cantaloupe and eggplant: The water extract of cantaloupe and eggplant used in this experiment was obtained through the second embodiment.
5.香瓜茄發酵汁液:此實驗中所使用的香瓜茄水萃液是透過如上實施例一所獲得。 5. Cantaloupe and eggplant fermented juice: The cantaloupe and eggplant water extract used in this experiment was obtained through Example 1 above.
B.實驗步驟 B. Experimental Procedure
1.於6孔培養盤中,每孔培養基中植入2x 106個人類周邊血單核球細胞(於後方步驟中將略稱為細胞)。 1. In a 6-well culture dish, 2×10 6 human peripheral blood mononuclear cells (abbreviated as cells in the following steps) were implanted in each well of culture medium.
2.於37℃培養24小時。 2. Incubate at 37°C for 24 hours.
3.將細胞分為三組:空白組、實驗組A、實驗組B。第一組為空白組(Mock);第二組(實驗組A)則加入香瓜茄水萃液,使加入香瓜茄發酵汁液後,整體溶液中的香瓜茄發酵汁液濃度為0.0625%;第三組(實驗組B)則加入香瓜茄發酵汁液,使加入香瓜茄發酵汁液後,整體溶液中的香瓜茄發酵汁液濃度為0.0625%;接著將N三組細胞於37℃培養24小時。 3. Divide the cells into three groups: blank group, experimental group A, and experimental group B. The first group was the blank group (Mock); the second group (experimental group A) added the water extract of cantaloupe tomato, so that after adding the cantaloupe tomato fermented juice, the concentration of the cantaloupe tomato fermented juice in the overall solution was 0.0625%; the third group (Experimental group B) added the cantaloupe tomato fermented juice, so that after adding the cantaloupe tomato fermented juice, the concentration of the cantaloupe tomato fermented juice in the overall solution was 0.0625%; then the cells of the three groups of N were cultured at 37°C for 24 hours.
4.收集細胞。 4. Harvest cells.
5.用磷酸鹽緩衝生理鹽水(Phosphate-Buffered Saline,PBS)(購自Gibco)沖洗一次。 5. Rinse once with Phosphate-Buffered Saline (PBS) (purchased from Gibco).
6.重懸浮細胞(Resuspend cells)於1毫升的PBS。 6. Resuspend cells in 1 ml of PBS.
7.以GSH試劑(1:1000)將細胞染色15分鐘。 7. Stain cells with GSH reagent (1:1000) for 15 minutes.
8.用PBS沖洗一次。 8. Rinse once with PBS.
9.重懸浮細胞(Resuspend cells)於200微升的PBS。 9. Resuspend cells in 200 μl of PBS.
10.通過流式細胞儀(購自BD Accuri,型號C6 Plus)分析相對的螢光異硫氰酸鹽(FITC)訊號。 10. Analyze relative fluorescent isothiocyanate (FITC) signal by flow cytometry (available from BD Accuri, model C6 Plus).
11.偵測出之數值以微軟EXCEL軟體,利用Student t檢定分析數值間的統計顯著性,其結果如圖1所示。其中,相較於空白組,***表示p<0.001。 11. Using Microsoft EXCEL software, the detected values were analyzed for statistical significance by Student's t test. The results are shown in Figure 1. Wherein, *** means p < 0.001 compared to blank group.
由圖2結果可知,有加入香瓜茄水萃液的第二組(實驗組A)細胞,GSH含量並無提升,反而相較於空白組降低7.41%;加入香瓜茄發酵汁液的第三組(實驗組B)細胞,GSH含量則是相較於空白組明顯提升8.34%,使其相對GSH含量(relative GSH content)為第一組(空白組)細胞的1.08倍,並為第二組(實驗組)細胞的1.17倍。GSH是由麩胺酸、胱胺酸和甘胺酸所組成的三胜肽,其硫醇基(-SH)與氧化還原相關,主要功能為細胞內生性抗氧化的防禦,可以對抗ROS的氧化傷害。因此,由圖1的結果亦可證實,添加本案實施例一而得之香瓜茄發酵汁液,確實可提升細胞中GSH含量,增加細胞內氧化還原的能力,以達到細胞抗氧化的功效。 It can be seen from the results in Figure 2 that the cells of the second group (experimental group A) added with the water extract of cantaloupe and eggplant, the GSH content did not increase, but decreased by 7.41% compared with the blank group; the third group ( In experimental group B) cells, the GSH content was significantly increased by 8.34% compared to the blank group, making its relative GSH content 1.08 times that of the cells in the first group (blank group), and was higher than that in the second group (experimental group). group) cells 1.17 times. GSH is a tripeptide composed of glutamic acid, cystine and glycine. Its thiol group (-SH) is related to redox, and its main function is the defense of cellular endogenous antioxidants, which can resist the oxidation of ROS. harm. Therefore, it can also be confirmed from the results in FIG. 1 that adding the cantaloupe tomato fermented juice obtained in Example 1 of the present case can indeed increase the GSH content in cells and increase the ability of intracellular redox, so as to achieve the effect of anti-oxidation in cells.
實施例五:抗醣化測試 Example 5: Anti-glycation test
以200mM磷酸鈉緩衝液(Sodium phosphate buffer,pH7.4)、疊氮化鈉(Sodium azide,NaN3)與牛血清白蛋白(Bovine serum albumin,BSA,品牌:Gibco)配置含有0.06%NaN3的60mg/mL BSA溶液。
200mM sodium phosphate buffer (Sodium phosphate buffer, pH 7.4), sodium azide (Sodium azide, NaN 3 ) and bovine serum albumin (BSA, brand: Gibco) were prepared with 0.06
以200mM磷酸鈉緩衝液與D果糖(D-(-)-Fructose,C6H12O6)配置1.5M D-fructose溶液。 A 1.5M solution of D-fructose was prepared in 200 mM sodium phosphate buffer and D-fructose (D-( - ) - Fructose, C6H12O6 ).
以200mM磷酸鈉緩衝液與氨基胍鹽酸鹽(Aminoguanidine hydrochloride,AG,CH6N4‧HCl)配置3mM AG溶液。 A 3 mM AG solution was prepared with 200 mM sodium phosphate buffer and aminoguanidine hydrochloride (AG, CH 6 N 4 ·HCl).
取0.25mL實施例二中所得到的香瓜茄水萃液加入0.25mL BSA溶液與D-fructose溶液並均勻混合以得到實驗組A的待測溶液。 Take 0.25 mL of the water extract of cantaloupe and eggplant obtained in Example 2, add 0.25 mL of BSA solution and D-fructose solution and mix them uniformly to obtain the test solution of experimental group A.
取0.25mL實施例一中所得到的香瓜茄發酵汁液加入0.25mL BSA溶液與D-fructose溶液並均勻混合以得到實驗組B的待測溶液。 Take 0.25 mL of the cantaloupe tomato fermented juice obtained in Example 1, add 0.25 mL of BSA solution and D-fructose solution and mix them uniformly to obtain the test solution of experimental group B.
取0.25mL之3mM AG溶液加入0.25mL BSA溶液與D-fructose溶液並均勻混合以得到空白組的待測溶液。 Take 0.25mL of 3mM AG solution, add 0.25mL of BSA solution and D-fructose solution and mix them uniformly to obtain the test solution of blank group.
取0.1mL各組別的待測溶液作為各組別的零點溶液。使用螢光分光光度計(Thermo Fisher Scientific)對0.1mL各組別的零點溶液以360nm之激發光以及460nm之放射光測定其螢光值,以得到反應前之零點之螢光值。 Take 0.1 mL of the solution to be tested in each group as the zero point solution for each group. Using a spectrophotometer (Thermo Fisher Scientific), the fluorescence values of 0.1 mL of each group of zero point solutions were measured with excitation light of 360 nm and emission light of 460 nm to obtain the fluorescence value of zero point before the reaction.
取0.45mL各組別的待測溶液於50℃下培養24小時,以得到各組別的終點溶液。取0.1mL各組別的終點溶液並使用螢光分光光度計對0.1mL各組別的終點溶液以360nm之激發光以及460nm之放射光測定其螢光值,以得到反應之終點之螢光值。 Take 0.45mL of the test solution of each group and incubate at 50°C for 24 hours to obtain the end point solution of each group. Take 0.1mL of the end point solution of each group and use a spectrophotometer to measure the fluorescence value of 0.1mL of the end point solution of each group with excitation light of 360nm and emission light of 460nm to obtain the fluorescence value of the end point of the reaction .
然後根據下列公式(1)計算各組別的相對醣化終產物(Advanced Glycation End products,AGEs)的形成量(%),以得知其抗醣化活性(Antiglycative activity)。換言之,於此,是將空白組的AGEs形成量視為1(即空白組的相對AGEs形成量為100%)來計算各組別的相對AGEs形成量(%)。 Then, the relative formation amount (%) of Advanced Glycation End products (AGEs) of each group was calculated according to the following formula (1) to know its antiglycative activity. In other words, here, the relative amount (%) of AGEs formed in each group was calculated by considering the amount of AGEs formed in the blank group as 1 (ie, the relative amount of AGEs formed in the blank group was 100%).
其中,Fluorescence sample 24hr代表實驗組的終點之螢光值,Fluorescence sample 0hr代表實驗組的零點之螢光值,Fluorescence control 24hr代表空白組的終點之螢光值,Fluorescence control 0hr代表空白組的零點之螢光值。 Among them, Fluorescence sample 24hr represents the fluorescence value of the endpoint of the experimental group, Fluorescence sample 0hr represents the fluorescence value of the zero point of the experimental group, Fluorescence control 24hr represents the fluorescence value of the endpoint of the blank group, and Fluorescence control 0hr represents the zero point of the blank group. Fluorescence value.
參照圖3,相較於空白組,實驗組A(水萃液)並無影響醣化終產物的形成量,而實驗組B(發酵汁液)明顯減少24.24%的醣化終產物的形成量。由此可知,香瓜茄發酵汁液能有效抑制醣化終產物的形成,即具有抗醣化的作用。 Referring to Figure 3, compared with the blank group, experimental group A (water extract) did not affect the formation of saccharification end products, while experimental group B (fermentation juice) significantly reduced the formation of saccharification end products by 24.24%. It can be seen that the cantaloupe tomato fermented juice can effectively inhibit the formation of end products of glycation, that is, it has the effect of anti-glycation.
實施例六:抗老基因檢測 Example 6: Anti-aging gene detection
此範例以RNA萃取套組、反轉錄酶、KAPA SYBR® FAST qPCR試劑組配合定量PCR儀,測定人類纖維母細胞受經香瓜茄水萃液或香瓜茄發酵汁液處理後,細胞中抗老化相關基因的變化。 This example uses RNA extraction kit, reverse transcriptase, KAPA SYBR® FAST qPCR reagent kit and quantitative PCR instrument to determine the anti-aging-related genes in human fibroblasts treated with cantaloupe water extract or cantaloupe fermented juice The change.
舉例來說,皮膚抗老化CCT5基因(Gene ID:22948)、FOXO基因(Gene ID:2308)、MRPS5基因(Gene ID:64969)、Pink1基因(Gene ID:65018)、Ubl-5基因(Gene ID:59286)。 For example, skin anti-aging CCT5 gene (Gene ID: 22948), FOXO gene (Gene ID: 2308), MRPS5 gene (Gene ID: 64969), Pink1 gene (Gene ID: 65018), Ubl-5 gene (Gene ID: 65018) : 59286).
其中,CCT5基因為CCT基因家族中的一員,與成熟細胞恢復年輕狀態的過程有關;Pink1基因與老化粒線體恢復年輕狀態的過程有關;FOXO基因、MRPS5基因、Ubl-5基因皆與粒線體活化的過程有關,粒線體就於同生物體內的發電廠,若粒線體的活性不足,容易引響細胞老 化現象。 Among them, CCT5 gene is a member of the CCT gene family, which is related to the process of mature cells returning to a young state; Pink1 gene is related to the process of restoring young state of aging mitochondria; FOXO gene, MRPS5 gene, and Ubl-5 gene are all related to mitochondrial mitochondria. It is related to the process of body activation, and mitochondria are the power plants in the living body. If the activity of mitochondria is insufficient, it is easy to cause cell aging. phenomenon.
因此,實施例六中以CCT5基因、FOXO基因、MRPS5基因、Pink1基因、Ubl-5基因作為抗老基因分析標的。 Therefore, in Example 6, CCT5 gene, FOXO gene, MRPS5 gene, Pink1 gene, and Ubl-5 gene are used as anti-aging gene analysis targets.
材料與儀器 Materials and Instruments
1.細胞株(下稱細胞):人類纖維母細胞(CCD-996SK,來自ATCC)。 1. Cell line (hereinafter referred to as cell): human fibroblasts (CCD-996SK, from ATCC).
2.培養基:最小必需培養液(Minimum essential medium)(MEM)(Gibco;型號:11095080),加入10%胎牛血清(FBS)(Gibco;型號:10437-028)、1%青黴素-鏈黴素(Gibco;型號:15140122)、1mM丙酮酸鈉(sodium pyruvate)(Gibco;型號:11360-070)、1.5g/l碳酸氫鈉(sodium bicarbonate)(Sigma;型號:S5761-500G),和0.1mM非必需胺基酸(non-essential amino acids)(Gibco;Cat.11140050)。 2. Medium: Minimum essential medium (MEM) (Gibco; model: 11095080), added with 10% fetal bovine serum (FBS) (Gibco; model: 10437-028), 1% penicillin-streptomycin (Gibco; model: 15140122), 1 mM sodium pyruvate (Gibco; model: 11360-070), 1.5 g/l sodium bicarbonate (Sigma; model: S5761-500G), and 0.1 mM Non-essential amino acids (Gibco; Cat. 11140050).
3.RNA萃取試劑套組(購自Geneaid公司,台灣,型號:.FC24015-G) 3. RNA extraction reagent kit (purchased from Geneaid, Taiwan, model: .FC24015-G)
4.反轉錄酶(SuperScript® III Reverse Transcriptase)(Invitrogen公司,美國,編號18080-051) 4. SuperScript® III Reverse Transcriptase (Invitrogen, USA, No. 18080-051)
5.測量標的基因引子,其中包含FOXO基因、MRPS5基因、Pink1基因、Ubl-5基因,另包括內部控制組(GAPDH基因)。 5. Measure target gene primers, which include FOXO gene, MRPS5 gene, Pink1 gene, Ubl-5 gene, and an internal control group (GAPDH gene).
6.KAPA SYBR® FAST qPCR試劑組(購自Sigma公司,美國,編號38220000000) 6. KAPA SYBR® FAST qPCR reagent set (purchased from Sigma, USA, No. 38220000000)
7.ABI StepOnePlusTM即時PCR系統(ABI StepOnePlusTM Real-Time PCR system(Thermo Fisher Scientific公司,美國))。 7. ABI StepOnePlus ™ real-time PCR system (ABI StepOnePlus ™ Real-Time PCR system (Thermo Fisher Scientific, USA)).
8.香瓜茄發酵汁液:此實驗中所使用的香瓜茄發酵汁液是透過如上實施例一所獲得。 8. Cantaloupe tomato fermented juice: The cantaloupe tomato fermented juice used in this experiment was obtained through Example 1 above.
9.香瓜茄水萃液:此實驗中所使用的香瓜茄水萃液是透過如上實施例二所獲得。 9. Water extract of cantaloupe and eggplant: The water extract of cantaloupe and eggplant used in this experiment was obtained through the second embodiment.
首先,將人類纖維母細胞(與此實施例簡稱為細胞)以每孔1×105個細胞量培養於含有2mL上述培養液之六孔培養盤中,並在37℃下培養16小時,然後將細胞分為以下三組:實驗組A、實驗組B與空白組。 First, human fibroblasts (referred to as cells in this example) were cultured at 1×10 5 cells per well in a six-well culture dish containing 2 mL of the above-mentioned culture medium, and cultured at 37° C. for 16 hours, and then The cells were divided into the following three groups: experimental group A, experimental group B and blank group.
測試條件 Test Conditions
詳細來說,實驗組A是將如上實施例所製備的香瓜茄水萃液2.0%濃度的培養基2ml,培養人類纖維母細胞24小時。實驗組B是將如上實施例所製備的香瓜茄發酵汁液2.0%濃度的培養基2ml,培養人類纖維母細胞24小時。 In detail, in experimental group A, human fibroblasts were cultured for 24 hours with 2 ml of the 2.0% concentration medium of the water extract of cantaloupe and eggplant prepared in the above example. In the experimental group B, human fibroblasts were cultured for 24 hours with 2 ml of the medium containing the 2.0% concentration of the cantaloupe tomato fermented juice prepared in the above example.
空白組是單純使用2毫升培養液來培養人類纖維母細胞,未再加入其他添加成分,培養人類纖維母細胞24小時,用於做為實驗空白組。 In the blank group, human fibroblasts were simply cultured with 2 ml of culture medium, and no other additives were added. Human fibroblasts were cultured for 24 hours and used as the experimental blank group.
以上實驗組A及實驗組B及空白組,每組進行四重複。 The above experimental group A, experimental group B and blank group, each group was repeated four times.
將處理後的人類纖維母細胞(即實驗組A及實驗組B)以及空白組的人類纖維母細胞以細胞裂解液分別破細胞膜以形成三組的細胞 溶液。接著,以RNA萃取試劑套組(購自Geneaid公司,台灣,Lot No.FC24015-G)分別萃取三組細胞溶液內的RNA。接著,每組取1000奈克(ng)的萃取出的RNA作為模板,透過SuperScript® III反轉錄酶(購自Invitrogene公司,美國,編號18080-051)將萃取出的RNA反轉錄為相應之cDNA。再藉由ABI StepOnePlusTM即時PCR系統(ABI StepOnePlusTM Real-Time PCR system(Thermo Fisher Scientific公司,美國))、KAPA SYBR FAST(購自Sigma公司,美國,編號38220000000)及表1的引子(SEQ ID NO:1至SEQ ID NO:12)對六組的cDNA進行定量即時反轉錄聚合酶連鎖反應(quantitative real-time reverse transcription polymerase chain reaction)以觀察三組的人類纖維母細胞內的CCT5基因、FOXO基因、MRPS5基因、Pink1基因、UBL5基因的表現量。定量即時反轉錄聚合酶連鎖反應的儀器設定條件為95℃反應20秒,接著95℃反應3秒,60℃反應30秒,並重複40個迴圈,並使用2-△Ct方法進行基因定量。於此,藉由cDNA進行定量即時反轉錄聚合酶連鎖反應可間接定量CCT5基因、FOXO基因、MRPS5基因、Pink1基因、UBL5基因的mRNA表現量,進而推斷CCT5基因、FOXO基因、MRPS5基因、Pink1基因、UBL5基因編碼的蛋白質的表現量。 The treated human fibroblasts (ie experimental group A and experimental group B) and the human fibroblasts in the blank group were respectively ruptured cell membranes with cell lysate to form three groups of cell solutions. Next, the RNAs in the cell solutions of the three groups were extracted with an RNA extraction reagent kit (purchased from Geneaid, Taiwan, Lot No. FC24015-G). Next, 1000 nanograms (ng) of the extracted RNA was used as a template for each group, and the extracted RNA was reverse transcribed into corresponding cDNA by SuperScript® III reverse transcriptase (purchased from Invitrogene, USA, No. 18080-051). . Then by ABI StepOnePlus TM real-time PCR system (ABI StepOnePlus TM Real-Time PCR system (Thermo Fisher Scientific Company, USA)), KAPA SYBR FAST (purchased from Sigma Company, USA, No. 38220000000) and the primer (SEQ ID of Table 1) NO: 1 to SEQ ID NO: 12) Quantitative real-time reverse transcription polymerase chain reaction (quantitative real-time reverse transcription polymerase chain reaction) was performed on the cDNA of six groups to observe the CCT5 gene, FOXO in human fibroblasts of three groups Gene, MRPS5 gene, Pink1 gene, UBL5 gene expression. The instrument setting conditions for quantitative real-time reverse transcription polymerase chain reaction were 95°C for 20 seconds, followed by 95°C for 3 seconds, 60°C for 30 seconds, and repeated 40 cycles, and the 2-ΔCt method was used for gene quantification. Here, quantitative real-time reverse transcription polymerase chain reaction with cDNA can indirectly quantify the mRNA expression levels of CCT5 gene, FOXO gene, MRPS5 gene, Pink1 gene, and UBL5 gene, and then infer CCT5 gene, FOXO gene, MRPS5 gene, and Pink1 gene. , the expression of the protein encoded by the UBL5 gene.
需要特別說明的是,下文述及之圖式中顯示的各基因的相對基因表現係以相對倍率呈現,其中使用Excel軟體之STDEV公式計算標準差,並在Excel軟體中以單尾學生t檢驗(Student t-test)分析是否具有統計上的顯著差異。圖式中「*」代表p值小於0.05,「**」代表p值小於0.01,以及「***」代表p值小於0.001。當「*」越多時,代表統計上的差異越顯著。 It should be noted that the relative gene expression of each gene shown in the figures described below is presented in relative magnification, wherein the standard deviation was calculated using the STDEV formula of Excel software, and the one-tailed Student's t test ( Student t-test) to analyze whether there is a statistically significant difference. In the graph, "*" represents a p-value less than 0.05, "**" represents a p-value less than 0.01, and "***" represents a p-value less than 0.001. The more "*", the more significant the statistical difference.
請參閱圖4。將空白組的CCT5基因的表現量視為1(即100%)時,實驗組A相對於空白組的CCT5基因的表現量為0.22(即22%)、實驗組B相對於空白組的CCT5基因的表現量為1.46(即146%),代表細胞經香瓜茄發酵汁液處理後,CCT5基因的表現量升高,為空白組的1.46倍。
See Figure 4. When the expression level of the CCT5 gene in the blank group was regarded as 1 (
請參閱圖4。將空白組的FOXO基因的表現量視為1(即100%)時,實驗組A相對於空白組的FOXO基因的表現量為0.25(即25%)、實驗組B相對於空白組的FOXO基因的表現量為1.58(即158%),
代表細胞經香瓜茄發酵汁液處理後,FOXO基因的表現量升高,為空白組的1.58倍。
See Figure 4. When the expression level of the FOXO gene in the blank group was regarded as 1 (
請參閱圖4。將空白組的MRPS5基因的表現量視為1(即100%)時,實驗組A相對於空白組的MRPS5基因的表現量為0.17(即17%)、實驗組B相對於空白組的MRPS5基因的表現量為1.12(即112%),代表細胞經香瓜茄發酵汁液處理後,MRPS5基因的表現量升高,為空白組的1.12倍。
See Figure 4. When the expression level of the MRPS5 gene in the blank group was regarded as 1 (
請參閱圖4。將空白組的Pink1基因的表現量視為1(即100%)時,實驗組A相對於空白組的Pink1基因的表現量為0.30(即30%)、實驗組B相對於空白組的Pink1基因的表現量為1.35(即135%),代表細胞經香瓜茄發酵汁液處理後,Pink1基因的表現量升高,為空白組的1.35倍。
See Figure 4. When the expression level of the Pink1 gene in the blank group is regarded as 1 (
請參閱圖4。將空白組的UBL5基因的表現量視為1(即100%)時,實驗組A相對於空白組的UBL5基因的表現量為0.25(即25%)、實驗組B相對於空白組的UBL5基因的表現量為1.48(即148%),代表細胞經香瓜茄發酵汁液處理後,實驗組的UBL5基因的表現量升高,為空白組的1.48倍。
See Figure 4. When the expression level of the UBL5 gene in the blank group was regarded as 1 (
由此可知,當人類纖維母細胞經香瓜茄發酵汁液處理後,細胞內與抗老回春相關的各種基因表現量提高,代表細胞由老化狀態回復到未老化前的狀態,有效的延緩了細胞的老化。 It can be seen that when human fibroblasts are treated with cantaloupe tomato fermented juice, the expression of various genes related to anti-aging and rejuvenation in the cells increases, which means that the cells return from the aging state to the state before the non-aging, effectively delaying the cell regeneration. Ageing.
實施例七:黑色素含量檢測 Embodiment 7: Detection of melanin content
於此,所使用的細胞培養基為添加有1vol%盤尼西林-鏈黴素(penicillin/streptomycin,品牌:Gibco)及10vol%胎牛血清(fetal bovine serum,FBS,品牌:Gibco)之杜貝可氏改良的依格氏培養基(Dulbecco’s Modified Eagle’s Medium,DMEM,品牌:Gibco)。 Here, the cell culture medium used was supplemented with 1 vol% penicillin/streptomycin (brand name: Gibco) and 10 vol% fetal bovine serum (fetal calf serum). bovine serum, FBS, brand: Gibco) of Dulbecco's Modified Eagle's Medium (DMEM, brand: Gibco).
首先,以每孔1.5×105個細胞的細胞數,將小鼠黑色素瘤細胞株B16F10(購自美國典型培養物保存中心(ATCC),編號CRL-6475)接種於含有3mL細胞培養基的6孔培養盤的各孔中,並置於37℃下培養24小時。 First, the mouse melanoma cell line B16F10 (purchased from the American Type Culture Collection (ATCC), accession number CRL-6475) was inoculated into 6 wells containing 3 mL of cell culture medium at a cell number of 1.5×10 5 cells per well. in each well of the culture plate and incubated at 37°C for 24 hours.
在培養24小時後,將B16F10細胞分成3個組別:一個實驗組(即實驗組(香瓜茄發酵汁液組))、一個對照組以及一個空白組。移除各組別的細胞培養基,並更換成每孔3mL實驗培養基,然後置於37℃下接續培養48小時。其中,實驗組的實驗培養基為含有0.03125vol%實施例一中所得到的香瓜茄發酵汁液的細胞培養基。對照組的實驗培養基為含有0.03125vol%麴酸(kojic acid)的細胞培養基(空白組的實驗培養基為單純的細胞培養基(即不含香瓜茄發酵汁液,也不含麴酸)。 After culturing for 24 hours, the B16F10 cells were divided into 3 groups: an experimental group (ie, the experimental group (cantaloupe tomato fermented juice group)), a control group, and a blank group. The cell culture medium of each group was removed and replaced with 3 mL of experimental medium per well, and then placed at 37° C. for 48 hours. Wherein, the experimental medium of the experimental group was a cell culture medium containing 0.03125 vol% of the cantaloupe tomato fermented juice obtained in Example 1. The experimental medium of the control group was a cell culture medium containing 0.03125 vol% kojic acid (the experimental medium of the blank group was a simple cell culture medium (that is, without the fermented juice of cantaloupe and without kojic acid).
於培養48小時後,移除各孔中的實驗培養基並以1倍(1x)的磷酸鹽緩衝液(phosphate buffered saline,PBS,品牌:Gibco)潤洗二次。於沖洗後,將胰蛋白酶(trypsin)加入至各孔中以處理細胞3分鐘。於3分鐘處理後,將各孔的懸浮的細胞個別收集於15mL離心管中,接而以400xg離心5分鐘以分離細胞沉澱物(cell pellet)與上清液。透過1xPBS再懸浮細胞沉澱物及離心反覆進行二次後,以200μL的1xPBS再懸浮細胞沉澱物,以得到細胞溶液。接著,將細胞溶液於液態氮中放置10分鐘,接而於室溫下靜置30分鐘進行解凍。在解凍完全之後,各離心管以12,000xg離心30分鐘。於30分鐘離心後,移除各離心管中上清液並添加入120μL 1N NaOH(配於ddH2O)以與各離心管中的沉澱物進行混合。在混合均勻之後,將含有混合溶液的各離心管於60℃乾浴槽中靜置1小時。之後,從各離心管中取100μL混合溶液至96孔培養盤中並於450nm的波長下以ELISA(enzyme-linked immunosorbent assay,酵素結合免疫吸附法)讀取儀(廠牌:BioTek)來讀取96孔培養盤中各孔的吸光值(OD450)。 After 48 hours of incubation, the experimental medium in each well was removed and rinsed twice with 1x (1x) phosphate buffered saline (PBS, brand: Gibco). After washing, trypsin was added to each well to treat the cells for 3 minutes. After 3 minutes of treatment, the suspended cells in each well were individually collected in 15 mL centrifuge tubes, and then centrifuged at 400×g for 5 minutes to separate the cell pellet and the supernatant. After the cell pellet was resuspended in 1xPBS and centrifugation was repeated twice, the cell pellet was resuspended with 200 μL of 1xPBS to obtain a cell solution. Next, the cell solution was placed in liquid nitrogen for 10 minutes, and then stood at room temperature for 30 minutes to thaw. After complete thawing, each centrifuge tube was centrifuged at 12,000 xg for 30 minutes. After 30 minutes of centrifugation, the supernatant in each centrifuge tube was removed and 120 μL of 1N NaOH (in ddH2O) was added to mix with the pellet in each centrifuge tube. After mixing uniformly, each centrifuge tube containing the mixed solution was left to stand in a 60°C dry bath for 1 hour. Then, take 100 μL of the mixed solution from each centrifuge tube into a 96-well culture plate and read it with an ELISA (enzyme-linked immunosorbent assay, enzyme-linked immunosorbent assay) reader (brand: BioTek) at a wavelength of 450 nm. Absorbance value (OD450) of each well in a 96-well plate.
於量測後,藉由將所測得的吸光值代入下列公式(2)而計算出相對黑色素含量(%)。換言之,於此,是將空白組的黑色素含量視為1(即空白組的相對黑色素含量為100%)來計算各組別的相對黑色素含量(%)。並且,各組之間的統計學顯著差異是藉由學生t-試驗(student t-test)來統計分析,如圖5所示。在圖5中,「*」代表在與空白組比較下其p值小於0.05,「**」代表在與空白組比較下其p值小於0.01,「***」代表在與空白組比較下其p值小於0.001。 After the measurement, the relative melanin content (%) was calculated by substituting the measured absorbance values into the following formula (2). In other words, here, the relative melanin content (%) of each group is calculated by considering the melanin content of the blank group as 1 (ie, the relative melanin content of the blank group is 100%). Also, statistically significant differences between groups were statistically analyzed by student t-test, as shown in FIG. 5 . In Figure 5, "*" represents that the p-value is less than 0.05 when compared with the blank group, "**" represents that the p-value is less than 0.01 when compared with the blank group, and "***" represents the comparison with the blank group. Its p-value is less than 0.001.
相對黑色素含量(%)=(OD450 sample/OD450 control)×100% Relative melanin content (%)=(OD450 sample/OD450 control)×100%
其中,OD450 sample代表欲換算之組別的吸光值,而OD450 control代表空白組的吸光值。 Among them, OD450 sample represents the absorbance value of the group to be converted, and OD450 control represents the absorbance value of the blank group.
參照圖5,相較於空白組,實驗組的黑色素含量有顯著地降低,且其可降低24.71%的黑色素生成;對照組的黑色素含量也顯著降低,其降低14.45%的黑色素生成,麴酸是已知的美白成分,由此可知,香瓜茄發酵汁液能有效抑制黑色素生成,即有效地抑制酪胺酸酶形成,具有美白之功效。 Referring to Figure 5, compared with the blank group, the melanin content of the experimental group was significantly reduced, and it could reduce the production of melanin by 24.71%; the melanin content of the control group was also significantly reduced, which reduced the production of melanin by 14.45%, and koji acid was Known whitening ingredients, it can be seen that the cantaloupe tomato fermented juice can effectively inhibit the formation of melanin, that is, effectively inhibit the formation of tyrosinase, and has the effect of whitening.
實施例八:保濕基因檢測 Example 8: Moisturizing gene detection
此範例以RNA萃取套組、反轉錄酶、KAPA SYBR® FAST qPCR試劑組配合定量PCR儀,測定人類初代皮膚角質細胞受經香瓜茄水萃液或香瓜茄發酵汁液處理後,細胞中保濕相關基因的變化。 In this example, RNA extraction kit, reverse transcriptase, KAPA SYBR® FAST qPCR reagent kit and quantitative PCR instrument are used to determine the moisturizing-related genes in primary human skin keratinocytes treated with cantaloupe water extract or cantaloupe fermented juice. The change.
舉例來說,保濕基因為Krt1基因(Gene ID:3848)及HAS2基因(Gene ID:3037) For example, the moisturizing genes are Krt1 gene (Gene ID: 3848) and HAS2 gene (Gene ID: 3037)
其中,Krt1基因與角蛋白有關,角蛋白為肌膚主要的構型物,緊密排列時具減少水分蒸散之鎖水功效,因此Krt1基因提升能影響肌膚保濕有關;;HAS2基因為玻尿酸合成酶相關基因,與玻尿酸合成有關,HAS2基因提升與玻尿酸含量有關,因此也能影響肌膚水潤和彈性。 Among them, the Krt1 gene is related to keratin, which is the main structure of the skin. When it is closely arranged, it has the effect of reducing water evapotranspiration and locking water. Therefore, the promotion of Krt1 gene can affect the skin moisturizing. The HAS2 gene is a hyaluronic acid synthase-related gene , It is related to the synthesis of hyaluronic acid, and the improvement of HAS2 gene is related to the content of hyaluronic acid, so it can also affect the moisture and elasticity of the skin.
因此,實施例八中以Krt1基因及HAS2基因作為分析標的。 Therefore, in Example 8, Krt1 gene and HAS2 gene were used as the analysis targets.
材料與儀器 Materials and Instruments
1.細胞株:細胞株:人類初代皮膚角質細胞(Human primary epidermal keratinocytes)(CELLnTEC公司(瑞士),HPEK-50)。 1. Cell line: Cell line: Human primary epidermal keratinocytes (CELLnTEC (Switzerland), HPEK-50).
2.培養基:Keratinocyte-SFM(1X)(Thermo)。 2. Medium: Keratinocyte-SFM (1X) (Thermo).
3.RNA萃取試劑套組(購自Geneaid公司,台灣,Lot No.FC24015-G) 3. RNA extraction reagent kit (purchased from Geneaid, Taiwan, Lot No.FC24015-G)
4.反轉錄酶(SuperScript® III Reverse Transcriptase)(Invitrogen公司,美國,編號18080-051) 4. SuperScript® III Reverse Transcriptase (Invitrogen, USA, No. 18080-051)
5.測量標的基因引子,其中包含Krt1基因及HAS2基因,另包括內部控制組(TBP基因)。 5. Measure the target gene primer, which includes Krt1 gene and HAS2 gene, and also includes internal control group (TBP gene).
6.KAPA SYBR® FAST qPCR試劑組(購自Sigma公司,美國,編號38220000000) 6. KAPA SYBR® FAST qPCR reagent set (purchased from Sigma, USA, No. 38220000000)
7.ABI StepOnePlusTM即時PCR系統(ABI StepOnePlusTM Real-Time PCR system(Thermo Fisher Scientific公司,美國))。 7. ABI StepOnePlus ™ real-time PCR system (ABI StepOnePlus ™ Real-Time PCR system (Thermo Fisher Scientific, USA)).
8.香瓜茄發酵汁液:此實驗中所使用的香瓜茄發酵汁液是透過如上實施例1所獲得。 8. Cantaloupe tomato fermented juice: The cantaloupe tomato fermented juice used in this experiment was obtained through Example 1 above.
9.香瓜茄水萃液:此實驗中所使用的香瓜茄水萃液是透過如上實施例2所獲得。 9. Water extract of cantaloupe and eggplant: The water extract of cantaloupe and eggplant used in this experiment was obtained through Example 2 above.
實驗步驟 Experimental procedure
首先,取1.5x105個人類初代皮膚角質細胞至每孔含有2毫升上述培養基的六孔細胞培養盤中,於37℃下培養24小時,將每孔培養後的人類初代皮膚角質細胞依據下列測試條件分為空白組以及實驗組(共二組)來處理每孔培養後的人類初代皮膚角質細胞。 First, take 1.5x10 5 human primary skin keratinocytes into a six-well cell culture dish containing 2 ml of the above-mentioned medium in each well, and culture at 37°C for 24 hours. The cultured primary human skin keratinocytes in each well were tested according to the following The conditions were divided into blank group and experimental group (two groups in total) to deal with the human primary skin keratinocytes cultured in each well.
測試條件 Test Conditions
詳細來說,空白組是單純使用2毫升培養液來培養人類初代皮膚角質細胞,未再加入其他添加成分,培養人類初代皮膚角質細胞6小時,用於做為實驗空白組。 In detail, the blank group simply used 2 ml of culture medium to culture primary human skin keratinocytes, without adding other ingredients, and cultured primary human skin keratinocytes for 6 hours, which was used as the experimental blank group.
實驗組是將含有如上實施例1所製備的香瓜茄發酵汁液1%濃度的培養基2ml,培養人類初代皮膚角質細胞6小時。 In the experimental group, human primary skin keratinocytes were cultured for 6 hours with 2 ml of culture medium containing 1% concentration of cantaloupe tomato fermented juice prepared in Example 1 above.
以上空白組及實驗組,每組進行四重複。 The blank group and the experimental group above were repeated four times in each group.
將處理後的人類初代皮膚角質細胞(即空白組及實驗組)以 細胞裂解液分別破細胞膜以形成二組的細胞溶液。接著,以RNA萃取試劑套組(購自Geneaid公司,台灣,Lot No.FC24015-G)分別萃取四組細胞溶液內的RNA。接著,每組取1000奈克(ng)的萃取出的RNA作為模板,透過SuperScript® III反轉錄酶(購自Invitrogene公司,美國,編號18080-051)將萃取出的RNA反轉錄為相應之cDNA。再藉由ABI StepOnePlusTM即時PCR系統(ABI StepOnePlusTM Real-Time PCR system(Thermo Fisher Scientific公司,美國))、KAPA SYBR FAST(購自Sigma公司,美國,編號38220000000)及表1的引子(SEQ ID NO:13及SEQ ID NO:18)對二組的cDNA進行定量即時反轉錄聚合酶連鎖反應(quantitative real-time reverse transcription polymerase chain reaction)以觀察二組的人類初代皮膚角質細胞內的Krt1基因、HAS2基因的表現量。定量即時反轉錄聚合酶連鎖反應的儀器設定條件為95℃反應20秒,接著95℃反應3秒,60℃反應30秒,並重複40個迴圈,並使用2-△Ct方法進行基因定量。於此,藉由cDNA進行定量即時反轉錄聚合酶連鎖反應可間接定量Krt1基因、HAS2基因的mRNA表現量,進而推斷Krt1基因、HAS2基因編碼的蛋白質的表現量。 The treated human primary skin keratinocytes (ie, blank group and experimental group) were respectively ruptured cell membranes with cell lysate to form two groups of cell solutions. Next, RNAs in four groups of cell solutions were extracted with RNA extraction reagent kits (purchased from Geneaid, Taiwan, Lot No. FC24015-G). Next, 1000 nanograms (ng) of the extracted RNA was used as a template for each group, and the extracted RNA was reverse transcribed into corresponding cDNA by SuperScript® III reverse transcriptase (purchased from Invitrogene, USA, No. 18080-051). . Then by ABI StepOnePlus TM real-time PCR system (ABI StepOnePlus TM Real-Time PCR system (Thermo Fisher Scientific Company, USA)), KAPA SYBR FAST (purchased from Sigma Company, USA, No. 38220000000) and the primer (SEQ ID of Table 1) NO: 13 and SEQ ID NO: 18) Quantitative real-time reverse transcription polymerase chain reaction (quantitative real-time reverse transcription polymerase chain reaction) was performed on the cDNAs of the two groups to observe the Krt1 gene, Expression of the HAS2 gene. The instrument setting conditions for quantitative real-time reverse transcription polymerase chain reaction were 95°C for 20 seconds, followed by 95°C for 3 seconds, 60°C for 30 seconds, and repeated 40 cycles, and the 2-ΔCt method was used for gene quantification. Here, quantitative real-time reverse transcription polymerase chain reaction with cDNA can indirectly quantify the mRNA expression levels of Krt1 and HAS2 genes, and then infer the expression levels of proteins encoded by Krt1 and HAS2 genes.
需要特別說明的是,下文述及之圖式中顯示的Krt1基因、HAS2基因的相對基因表現係以相對倍率呈現,其中使用Excel軟體之STDEV公式計算標準差,並在Excel軟體中以單尾學生t檢驗(Student t-test)分析是否具有統計上的顯著差異。圖式中「*」代表p值小於0.05,「**」代表p值小於0.01,以及「***」代表p值小於0.001。當「*」越多時,代表統計上的差異越顯著。 It should be noted that the relative gene expression of Krt1 gene and HAS2 gene shown in the diagrams described below is presented in relative magnification, wherein the standard deviation is calculated using the STDEV formula of Excel software, and the one-tailed student is used in Excel software. Student t-test was used to analyze whether there were statistically significant differences. In the graph, "*" represents a p-value less than 0.05, "**" represents a p-value less than 0.01, and "***" represents a p-value less than 0.001. The more "*", the more significant the statistical difference.
請參閱圖6,將空白組的HAS2基因和KRT1基因的表現量視為1(即100%)時,實驗組相對於空白組的HAS2基因的表現量為1.43(即143%)、KRT1基因的表現量為2.27(即227%),代表實驗組的HAS2基因的表現量上升為空白組的1.43倍,KRT1基因的表現量上升為空白組的2.27倍。 Referring to Figure 6, when the expression level of HAS2 gene and KRT1 gene in the blank group is regarded as 1 (ie, 100%), the expression level of the HAS2 gene in the experimental group relative to the blank group is 1.43 (ie, 143%), and the expression level of the KRT1 gene is 1.43 (ie, 143%). The expression level was 2.27 (ie, 227%), representing that the expression level of the HAS2 gene in the experimental group was 1.43 times higher than that in the blank group, and the expression level of KRT1 gene was 2.27 times higher than that in the blank group.
換言之,實驗組相較於空白組的HAS2基因的表現量上升43%、KRT1基因的表現量上升127%。 In other words, compared with the blank group, the expression of HAS2 gene in the experimental group increased by 43%, and the expression of KRT1 gene increased by 127%.
結果如圖6所示,當人類初代皮膚角質細胞以香瓜茄發酵汁液處理後,人類初代皮膚角質細胞的HAS2基因、KRT1基因的表現量上升,代表香瓜茄發酵汁液具調節角蛋白及玻尿酸含量之能力,具提升肌膚保濕能力之潛力。 The results are shown in Figure 6. When the primary human skin keratinocytes were treated with cantaloupe tomato fermented juice, the expression of HAS2 gene and KRT1 gene in the primary human skin keratinocytes increased, indicating that the cantaloupe tomato fermented juice could regulate the content of keratin and hyaluronic acid. It has the potential to enhance the skin's moisturizing ability.
實施例九:脂肪累積檢測 Example 9: fat accumulation detection
於此,所使用的前脂肪細胞增殖培養基(pre-adipocyte expansion medium)為添加有20vol% FBS(品牌:Gibco)及1vol%盤尼西林-鏈黴素之最低必需培養基α(Minimum Essential Medium Alpha,MEMα,品牌:Gibco)。所使用的分化培養基(differentiation medium)為添加有20vol% FBS(品牌:Gibco)及1vol%盤尼西林-鏈黴素之MEMα(品牌:Gibco)。並且,將油-紅O染色試劑(品牌:Sigma)徹底溶解於100%異丙醇(isopropanol,供應商:ECHO)以配製3mg/mL之油-紅O染色試劑的儲備溶液。為獲得可供使用的油-紅O工作溶液(oil-red O working solution),於使用前即時將油-紅O染色試劑的儲備溶液以二次水(ddH2O)稀釋至濃度1.8mg/mL,即為60%油-紅O染色試劑的儲備溶液。 Here, the pre-adipocyte expansion medium used is the minimum essential medium α (Minimum Essential Medium Alpha, MEMα, 20 vol% FBS (brand name: Gibco) and 1 vol% penicillin-streptomycin) supplemented with Brand: Gibco). The differentiation medium used was MEMα (brand: Gibco) supplemented with 20 vol% FBS (brand: Gibco) and 1 vol% penicillin-streptomycin. And, Oil-Red O staining reagent (brand: Sigma) was thoroughly dissolved in 100% isopropanol (isopropanol, supplier: ECHO) to prepare a 3 mg/mL stock solution of Oil-Red O staining reagent. To obtain a ready-to-use oil-red O working solution, dilute the stock solution of oil-red O staining reagent with secondary water (ddH2O) to a concentration of 1.8 mg/mL immediately before use, This is a stock solution of 60% Oil-Red O staining reagent.
首先,以每孔8×104個細胞的細胞數,將小鼠骨髓基質細胞株OP9(購自ATCC,編號CRL-2749)接種於含有500μL前脂肪細胞增殖培養基的24孔培養盤的各孔中,並置於37℃下培養7天。於7天的培養期間,每3天更換一次新鮮的500μL分化培養基。於培養7天後,使用顯微鏡(廠牌:ZEISS)觀察各孔中的細胞內的油滴(lipid droplet)形成以確認細胞完全分化成脂肪細胞,供後續實驗使用。 First, the mouse bone marrow stromal cell line OP9 (purchased from ATCC, No. CRL-2749) was inoculated into each well of a 24-well culture plate containing 500 μL of preadipocyte proliferation medium at a cell number of 8×10 4 cells per well. and cultured at 37°C for 7 days. During the 7-day culture period, fresh 500 μL differentiation medium was replaced every 3 days. After 7 days of culture, the formation of lipid droplets in the cells in each well was observed using a microscope (brand: ZEISS) to confirm that the cells were fully differentiated into adipocytes for subsequent experiments.
在培養24小時後,將脂肪細胞分成3個組別:二個實驗組(即實驗組A(香瓜茄水萃液)與實驗組B(香瓜茄發酵汁液))以及空白組。移除各組別的分化培養基,並更換成每孔500μL實驗培養基,然後置於37℃下接續培養7天。於7天的培養期間,每3天更換一次新鮮的500μL實驗培養基。其中,實驗組A的實驗培養基為含有0.0625vol%例一中所得到 的香瓜茄水萃液的分化培養基。實驗組B的實驗培養基為含有0.0625vol%例一中所得到的香瓜茄發酵汁液的分化培養基。空白組的實驗培養基為單純的分化培養基(即不含香瓜茄水萃液亦不含香瓜茄發酵汁液)。 After 24 hours of culture, the adipocytes were divided into 3 groups: two experimental groups (ie, experimental group A (water extract of cantaloupe) and experimental group B (fermented juice of cantaloupe) and blank group. The differentiation medium of each group was removed and replaced with 500 μL of experimental medium per well, and then cultured at 37° C. for 7 days. During the 7-day culture period, fresh 500 μL experimental medium was replaced every 3 days. Among them, the experimental medium of experimental group A was obtained in Example 1 containing 0.0625vol% Differentiation medium of cantaloupe water extract. The experimental medium of experimental group B was a differentiation medium containing 0.0625 vol% of the cantaloupe tomato fermented juice obtained in Example 1. The experimental medium of the blank group was a simple differentiation medium (that is, without the water extract of cantaloupe and the fermented juice of cantaloupe).
接著,移除各孔中的實驗培養基並以1xPBS潤洗二次。繼而,於各孔內添加1mL的10%甲醛(formaldehyde,供應商:ECHO)並於室溫下培養30分鐘,藉以固定細胞。之後,移除各孔內的甲醛並以1mL PBS對各孔潤洗二次。於再次潤洗後,添加1mL的60%異丙醇至每孔中並作用1分鐘。接著,移除異丙醇,再添加1mL油-紅O工作溶液並於室溫下作用1小時。 Next, the experimental medium in each well was removed and rinsed twice with IxPBS. Then, 1 mL of 10% formaldehyde (supplier: ECHO) was added to each well and incubated at room temperature for 30 minutes to fix the cells. Afterwards, the formaldehyde in each well was removed and each well was rinsed twice with 1 mL of PBS. After re-rinsing, 1 mL of 60% isopropanol was added to each well and allowed to act for 1 minute. Next, the isopropanol was removed and an additional 1 mL of Oil-Red O working solution was added and allowed to act at room temperature for 1 hour.
於作用1小時候,移除油-紅O工作溶液並以1mL的60%異丙醇快速退染5秒。於退染後,染色後的細胞以1xPBS潤洗後,加入100%異丙醇至各孔中,並置於振盪器(shaker)上反應10分鐘以溶解染劑。然後,從各孔中取100μL前述之溶染劑-異丙醇溶液至96孔培養盤並於510nm的波長下以ELISA讀取儀(廠牌:BioTek)讀取各孔的吸光值(OD510)。 After 1 hour of exposure, the Oil-Red O working solution was removed and rapidly destained with 1 mL of 60% isopropanol for 5 seconds. After destaining, the stained cells were rinsed with 1×PBS, 100% isopropanol was added to each well, and the cells were placed on a shaker to react for 10 minutes to dissolve the dye. Then, 100 μL of the aforementioned dye-isopropanol solution was taken from each well to a 96-well culture plate and the absorbance (OD510) of each well was read with an ELISA reader (brand: BioTek) at a wavelength of 510 nm. .
於量測後,藉由將所測得的吸光值代入下列公式(3)而計算出相對脂肪油滴量(%)。換言之,於此,是將空白組的脂肪油滴量視為1(即空白組的相對脂肪油滴量為100%)來計算各組別的相對脂肪油滴量(%)。並且,各組之間的統計學顯著差異是藉由學生t-試驗來統計分析,如圖4所示。在圖4中,「**」代表在與空白組比較下其p值小於0.01。 After the measurement, the relative fatty oil droplet amount (%) was calculated by substituting the measured absorbance value into the following formula (3). In other words, here, the relative fatty oil droplet amount (%) of each group is calculated by considering the amount of fatty oil droplets in the blank group as 1 (ie, the relative amount of fatty oil droplets in the blank group is 100%). Also, statistically significant differences between groups were statistically analyzed by Student's t-test, as shown in FIG. 4 . In Figure 4, "**" represents that the p-value is less than 0.01 in comparison with the blank group.
相對脂肪油滴量(%)=(OD510 sample/OD510 control)×100% (3) Relative fat droplet amount (%)=(OD510 sample/OD510 control)×100% (3)
其中,OD510 sample代表欲換算之組別的吸光值,而OD510 control代表空白組的吸光值。 Among them, OD510 sample represents the absorbance value of the group to be converted, and OD510 control represents the absorbance value of the blank group.
參照圖4,相較於空白組,實驗組A的相對脂肪油滴量有顯著地降低,且其可減少11.72%的油滴量。相較於空白組,實驗組B的相對脂肪油滴量有顯著地降低,且其可減少32.29%的油滴量。由此可知,香瓜茄發酵汁液能有效地抑制脂肪累積,具有減脂之功效。並且,香瓜茄透過微生物發酵後可能產出較香瓜茄培養液更多的減脂活性成分。 Referring to FIG. 4 , compared with the blank group, the relative amount of fatty oil droplets in the experimental group A was significantly reduced, and it could reduce the amount of oil droplets by 11.72%. Compared with the blank group, the relative amount of oil droplets in experimental group B was significantly reduced, and it could reduce the amount of oil droplets by 32.29%. It can be seen that the cantaloupe tomato fermented juice can effectively inhibit the accumulation of fat and has the effect of reducing fat. Moreover, the cantaloupe eggplant may produce more fat-reducing active ingredients than the cantaloupe eggplant culture medium after microbial fermentation.
實施例十:減脂功效試驗 Example ten: fat-reducing efficacy test
減脂是指脂肪被分解,而脂肪分解(Lipolysis)作用是指脂肪細胞內所貯存的三酸甘油酯(triglyceride,TG)被逐步降解為脂肪酸(fatty acid,FA)與甘油(Glycerol)的過程。基此,本次試驗分析脂肪細胞中甘油(Glycerol)的含量作為量化指標,以觀察是否有產生脂肪分解作用。 Fat loss refers to the decomposition of fat, and lipolysis refers to the process in which triglyceride (TG) stored in fat cells is gradually degraded into fatty acid (FA) and glycerol (Glycerol). . Based on this, in this experiment, the content of glycerol (Glycerol) in adipocytes was analyzed as a quantitative index to observe whether there is a lipolytic effect.
本次試驗採用小鼠骨髓基質細胞(後續簡稱OP9細胞),購自美國典型培養物保存中心(American Type Culture Collection,ATCC®)之OP9細胞株(ATCC CRL-2749)。 Mouse bone marrow stromal cells (hereinafter referred to as OP9 cells) were used in this experiment, and the OP9 cell line (ATCC CRL-2749) was purchased from the American Type Culture Collection (ATCC ® ).
首先,取24孔培養盤將每孔接種8×104個OP9細胞及500μL培養基(Medium),前培養基其中包含80%之MEMAM(Minimum Essential Medium Alpha Medium,購自Gibco,美國)細胞培養液、20%之胎牛血清(Fetal Bovine Serum,購自Gibco,美國,Cat#10437-028),且加入0.1%之青黴素/鏈黴素(Penicillin-streptomycin,購自Gibco,美國),在37℃下培養7天。此7天的細胞培養期間每隔3天更換培養基。7天後,以顯微鏡(ZEISS;放大倍率400x)觀察細胞內油滴形成,藉以確 認細胞已完全分化為脂肪細胞。 First, take a 24-well culture plate and inoculate each well with 8×10 4 OP9 cells and 500 μL of medium (Medium), which contains 80% MEMAM (Minimum Essential Medium Alpha Medium, purchased from Gibco, USA) cell culture medium, 20% Fetal Bovine Serum (Fetal Bovine Serum, available from Gibco, USA, Cat# 10437-028) and added with 0.1% Penicillin-streptomycin (available from Gibco, USA) at 37°C Cultured for 7 days. The medium was changed every 3 days during this 7-day cell culture period. After 7 days, intracellular oil droplet formation was observed under a microscope (ZEISS; magnification 400x) to confirm that the cells had fully differentiated into adipocytes.
然後,將分化完成的脂肪細胞分為二組:二個實驗組(即實驗組A(添加實施例二所製備的香瓜茄水萃液)與實驗組B(添加實施例一所製備的香瓜茄發酵汁液))以及空白組。 Then, the differentiated adipocytes were divided into two groups: two experimental groups (that is, experimental group A (adding the cantaloupe and eggplant water extract prepared in Example 2) and experimental group B (adding the cantaloupe eggplant prepared in Example 1) fermented juice)) and blank group.
實驗組A:依照每孔500μL培養基含有0.156μL的香瓜茄水萃液的比例(即,濃度為0.03125%)將香瓜茄水萃液添加至含分化後的培養基中,在37℃下培養7天。在7天的細胞處理期間每隔3天更換培養基。 Experimental group A: According to the ratio of 500 μL medium containing 0.156 μL of cantaloupe water extract per well (ie, the concentration is 0.03125%), the water extract of cantaloupe and eggplant was added to the differentiated medium, and cultured at 37°C for 7 days . The medium was changed every 3 days during the 7 days of cell treatment.
實驗組B:依照每孔500μL培養基含有0.156μL的香瓜茄發酵汁液的比例(即,濃度為0.03125%)將香瓜茄發酵汁液添加至含分化後的培養基中,在37℃下培養7天。在7天的細胞處理期間每隔3天更換培養基。 Experimental group B: The cantaloupe fermented juice was added to the differentiated medium according to the ratio of 0.156 μL of cantaloupe tomato fermented juice per well of 500 μL medium (ie, the concentration was 0.03125%), and cultured at 37° C. for 7 days. The medium was changed every 3 days during the 7 days of cell treatment.
空白組:不作任何處理,即不額外添加其他成分至含分化後的培養基中,在37℃下培養7天。在7天的細胞處理期間每隔3天更換培養基。 Blank group: no treatment, that is, no additional components were added to the differentiated medium, and cultured at 37°C for 7 days. The medium was changed every 3 days during the 7 days of cell treatment.
於7天的細胞處理後,使用細胞甘油基檢測試劑套組(Glycerol cell-based assay kit,購自Cayman,美國,產品編號10011725)依據下列步驟測量甘油含量。收集各組的上清液,並各取其中的25μL轉移到新的96孔培養盤中,並於各孔中加入100μL之重構游離甘油測定試劑(Reconstituted free glycerol assay reagent),再於室溫下作用15分鐘後,將培養盤以ELISA讀數器讀取各組之OD540nm的吸光度,以量化各組脂肪細胞分解並釋放至細胞培養液中的甘油量,如圖6所示。於此,甘油量的多寡與脂肪的分解量成正比。其中,利用Excel軟體進行student t-test 以決定兩個樣本群體之間是否在統計上具有顯著差異(圖式中「*」代表p值小於0.05,「**」代表p值小於0.01,以及「***」代表p值小於0.001。當「*」越多時,代表統計上的差異越顯著)。 After 7 days of cell treatment, glycerol content was measured using the Glycerol cell-based assay kit (available from Cayman, USA, product number 10011725) according to the following procedure. Collect the supernatant of each group, and transfer 25 μL of each to a new 96-well culture plate, and add 100 μL of Reconstituted free glycerol assay reagent to each well, and then at room temperature After 15 minutes of action, the absorbance at OD 540nm of each group was read with an ELISA reader to quantify the amount of glycerol decomposed and released into cell culture medium by adipocytes in each group, as shown in FIG. 6 . Here, the amount of glycerin is proportional to the amount of decomposition of fat. Among them, use Excel software to perform student t-test to determine whether there is a statistically significant difference between the two sample groups ("*" in the diagram represents p-value less than 0.05, "**" represents p-value less than 0.01, and "***" means p-value is less than 0.001. When there are more "*", it means the statistical difference is more significant).
參考圖8。將空白組的脂肪分解量視為100%時,實驗組A的脂肪分解量為96.07%,實驗組B的脂肪分解量為104.85%,也就是說香瓜茄發酵汁液處理的之後能顯著地提升4.85%的脂肪分解量。此結果顯示,香瓜茄發酵汁液能直接且有效促進脂肪細胞中脂肪分解,以減少脂肪細胞中脂肪的含量,而達到燃脂減肥的功效。 Refer to Figure 8. When the lipolysis of the blank group was regarded as 100%, the lipolysis of experimental group A was 96.07%, and the lipolysis of experimental group B was 104.85%. % of lipolysis. The results show that the cantaloupe tomato fermented juice can directly and effectively promote the decomposition of fat in adipocytes, so as to reduce the content of fat in adipocytes, and achieve the effect of burning fat and losing weight.
實施例十一-脂肪代謝基因的細胞實驗 Example 11 - Cell Experiment of Fat Metabolism Gene
此範例以RNA萃取套組、反轉錄酶、KAPA SYBR® FAST qPCR試劑組配合定量PCR儀,測定小鼠骨髓基質細胞受經香瓜茄水萃液或香瓜茄發酵汁液處理後,細胞中脂肪代謝基因基因的變化。 This example uses RNA extraction kit, reverse transcriptase, KAPA SYBR® FAST qPCR reagent kit and quantitative PCR instrument to determine the lipid metabolism genes in mouse bone marrow stromal cells treated with cantaloupe water extract or cantaloupe fermented juice genetic changes.
舉例來說,脂肪代謝基因基因為UCP2基因(Gene ID:7351)。 For example, the fat metabolism gene gene is the UCP2 gene (Gene ID: 7351).
其中,UCP2(Uncoupling Protein 2)基因所編碼的蛋白質為體解偶聯蛋白(UCP),其為線粒體陰離子載體蛋白(Mitochondrial anion carrier proteins,MACP)家族的成員之一,主要功能為將三磷酸腺核苷(Adenosine triphosphate,ATP)還原,並促進陰離子從線粒體的內膜向外轉移,及促進質子從外部到線粒體內膜的返迴轉移,並將過程中產生的能量以熱能釋放出來;UCP2基因在許多組織中表達,且以骨骼肌表達量最高,被認為與非顫抖性生熱(Nonshivering thermogenesis)有關。因此,UCP2基因的表現量上升,能夠促進脂肪的分解,並使脂肪的累積 量降低。 Among them, the protein encoded by the UCP2 (Uncoupling Protein 2) gene is the uncoupling protein (UCP), which is one of the members of the mitochondrial anion carrier protein (Mitochondrial anion carrier proteins, MACP) family. Nucleoside (Adenosine triphosphate, ATP) reduction, and promote the transfer of anions from the inner membrane of mitochondria to the outside, and promote the return transfer of protons from the outside to the inner membrane of mitochondria, and release the energy generated in the process as heat; UCP2 gene It is expressed in many tissues, with the highest expression in skeletal muscle, and is considered to be related to nonshivering thermogenesis. Therefore, the expression level of the UCP2 gene increases, which can promote the decomposition of fat and accumulate fat. amount decreased.
因此,實施例十一中以UCP2基因作為分析標的。 Therefore, in Example 11, the UCP2 gene was used as the analysis target.
材料與儀器 Materials and Instruments
10.細胞株:小鼠骨髓基質細胞OP9(BCRC;編號CRL-2749)。 10. Cell line: mouse bone marrow stromal cell OP9 (BCRC; No. CRL-2749).
11.培養基:包含80%之MEMAM(Minimum Essential Medium Alpha Medium,購自Gibco,美國)細胞培養液、20%之胎牛血清(Fetal Bovine Serum,購自Gibco,美國,Cat#10437-028),且加入0.1%之青黴素/鏈黴素(Penicillin-streptomycin,購自Gibco,美國)。 11. Culture medium: containing 80% MEMAM (Minimum Essential Medium Alpha Medium, purchased from Gibco, USA) cell culture medium, 20% Fetal Bovine Serum (purchased from Gibco, USA, Cat#10437-028), And 0.1% penicillin/streptomycin (Penicillin-streptomycin, purchased from Gibco, USA) was added.
12.RNA萃取試劑套組(購自Geneaid公司,台灣,Lot No.FC24015-G) 12. RNA extraction reagent kit (purchased from Geneaid, Taiwan, Lot No.FC24015-G)
13.反轉錄酶(SuperScript® III Reverse Transcriptase)(Invitrogen公司,美國,編號18080-051) 13. SuperScript® III Reverse Transcriptase (Invitrogen, USA, No. 18080-051)
14.測量標的基因引子,其中包含UCP2基因,另包括內部空白組(m-ACTB基因)。 14. The measurement target gene primer, which contains the UCP2 gene, and the internal blank group (m-ACTB gene).
15.KAPA SYBR® FAST qPCR試劑組(購自Sigma公司,美國,編號38220000000) 15. KAPA SYBR® FAST qPCR reagent set (purchased from Sigma, USA, No. 38220000000)
16.ABI StepOnePlusTM即時PCR系統(ABI StepOnePlusTM Real-Time PCR system(Thermo Fisher Scientific公司,美國))。 16. ABI StepOnePlus ™ real-time PCR system (ABI StepOnePlus ™ Real-Time PCR system (Thermo Fisher Scientific, USA)).
17.香瓜茄發酵汁液:此實驗中所使用的香瓜茄水萃液是透過如上實施例一所獲得。 17. Cantaloupe and eggplant fermentation juice: The cantaloupe and eggplant water extract used in this experiment was obtained through the above Example 1.
18.香瓜茄水萃液:此實驗中所使用的香瓜茄水萃液是透過如上實施例二所獲得。 18. Water extract of cantaloupe and eggplant: The water extract of cantaloupe and eggplant used in this experiment was obtained through the second embodiment.
實驗步驟 Experimental procedure
首先,取1.5x105個小鼠骨髓基質細胞OP9至每孔含有2毫升上述培養基的六孔細胞培養盤中,於37℃下培養24小時,將每孔培養後的小鼠骨髓基質細胞OP9依據下列測試條件分為空白組以及實驗組(共三組)來處理每孔培養後的小鼠骨髓基質細胞。 First, take 1.5x10 5 mouse bone marrow stromal cells OP9 into a six-well cell culture dish containing 2 ml of the above medium in each well, and culture at 37°C for 24 hours. The following test conditions were divided into blank group and experimental group (three groups in total) to treat the cultured mouse bone marrow stromal cells in each well.
測試條件 Test Conditions
詳細來說,空白組是單純使用2毫升培養液來培養小鼠骨髓基質細胞,未再加入其他添加成分,培養6小時,用於做為實驗空白組。 In detail, the blank group simply used 2 ml of culture medium to culture mouse bone marrow stromal cells, without adding other additives, and cultured for 6 hours, which was used as the experimental blank group.
實驗組A是將如上實施例所製備的香瓜茄水萃液0.0625%濃度的培養基2ml,培養小鼠骨髓基質細胞6小時。 In the experimental group A, 2 ml of the culture medium of 0.0625% concentration of the water extract of cantaloupe and eggplant prepared in the above example was used to culture the mouse bone marrow stromal cells for 6 hours.
實驗組B是將如上實施例所製備的香瓜茄發酵汁液0.0625%濃度的培養基2ml,培養小鼠骨髓基質細胞6小時。 In the experimental group B, 2 ml of the culture medium of 0.0625% concentration of cantaloupe tomato fermented juice prepared in the above example was used to culture mouse bone marrow stromal cells for 6 hours.
以上空白組、實驗組A、實驗組B,每組進行四重複。 The above blank group, experimental group A, and experimental group B were repeated four times in each group.
將處理後的小鼠骨髓基質細胞(即空白組、實驗組A、實驗組B)以細胞裂解液分別破細胞膜以形成三組的細胞溶液。接著,以RNA萃取試劑套組(購自Geneaid公司,台灣,Lot No.FC24015-G)分別萃取三組細胞溶液內的RNA。接著,每組取1000奈克(ng)的萃取出的RNA作為模板,透過SuperScript® III反轉錄酶(購自Invitrogene公司,美國, 編號18080-051)將萃取出的RNA反轉錄為相應之cDNA。再藉由ABI StepOnePlusTM即時PCR系統(ABI StepOnePlusTM Real-Time PCR system(Thermo Fisher Scientific公司,美國))、KAPA SYBR FAST(購自Sigma公司,美國,編號38220000000)及表1的引子(SEQ ID NO:19至SEQ ID NO:22)對三組的cDNA進行定量即時反轉錄聚合酶連鎖反應(quantitative real-time reverse transcription polymerase chain reaction)以觀察三組的小鼠骨髓基質細胞內的UCP2基因的表現量。定量即時反轉錄聚合酶連鎖反應的儀器設定條件為95℃反應20秒,接著95℃反應3秒,60℃反應30秒,並重複40個迴圈,並使用2-△Ct方法進行基因定量。於此,藉由cDNA進行定量即時反轉錄聚合酶連鎖反應可間接定量UCP2基因的mRNA表現量,進而推斷UCP2基因編碼的蛋白質的表現量。 The treated mouse bone marrow stromal cells (ie, blank group, experimental group A, and experimental group B) were broken into cell membranes with cell lysate to form cell solutions of three groups. Next, the RNAs in the cell solutions of the three groups were extracted with an RNA extraction reagent kit (purchased from Geneaid, Taiwan, Lot No. FC24015-G). Next, 1000 nanograms (ng) of the extracted RNA was taken as a template for each group, and the extracted RNA was reverse transcribed into corresponding cDNA through SuperScript® III reverse transcriptase (purchased from Invitrogene, USA, No. 18080-051). . Then by ABI StepOnePlus TM real-time PCR system (ABI StepOnePlus TM Real-Time PCR system (Thermo Fisher Scientific Company, USA)), KAPA SYBR FAST (purchased from Sigma Company, USA, No. 38220000000) and the primer (SEQ ID of Table 1) NO: 19 to SEQ ID NO: 22) Quantitative real-time reverse transcription polymerase chain reaction (quantitative real-time reverse transcription polymerase chain reaction) was performed on the cDNAs of the three groups to observe the UCP2 gene expression in the mouse bone marrow stromal cells of the three groups. performance. The instrument setting conditions for quantitative real-time reverse transcription polymerase chain reaction were 95°C for 20 seconds, followed by 95°C for 3 seconds, 60°C for 30 seconds, and repeated 40 cycles, and the 2-ΔCt method was used for gene quantification. Here, quantitative real-time reverse transcription polymerase chain reaction with cDNA can indirectly quantify the mRNA expression level of the UCP2 gene, thereby inferring the expression level of the protein encoded by the UCP2 gene.
需要特別說明的是,下文述及之圖式中顯示的UCP2的相對基因表現係以相對倍率呈現,其中使用Excel軟體之STDEV公式計算標準差,並在Excel軟體中以單尾學生t檢驗(Student t-test)分析是否具有統計上的顯著差異。圖式中「*」代表p值小於0.05,「**」代表p值小於0.01, 以及「***」代表p值小於0.001。當「*」越多時,代表統計上的差異越顯著。 It should be noted that the relative gene expression of UCP2 shown in the figures described below is presented in relative magnification, in which the standard deviation was calculated using the STDEV formula of Excel software, and the one-tailed Student t test (Student t-test) was used in Excel software. t-test) to analyze whether there is a statistically significant difference. In the figure, "*" represents p-value less than 0.05, "**" represents p-value less than 0.01, And "***" means p-value less than 0.001. The more "*", the more significant the statistical difference.
請參閱圖9,將空白組的UCP2基因的表現量視為1(即100%)時,實驗組A相對於空白組的UCP2基因的表現量為1.26(即126%),實驗組B相對於空白組的UCP2基因的表現量為4.75(即475%),代表實驗組A的UCP2基因的表現量上升為空白組的1.26倍,實驗組實驗組B的UCP2基因的表現量上升為空白組的4.75倍。
Referring to Figure 9, when the expression level of the UCP2 gene in the blank group is regarded as 1 (
換言之,實驗組A相較於空白組的UCP2基因的表現量上升26%,實驗組B相較於空白組的UCP2基因的表現量上升375%。 In other words, the expression of UCP2 gene in experimental group A increased by 26% compared with the blank group, and the expression of UCP2 gene in experimental group B increased by 375% compared with the blank group.
由此可知,當小鼠骨髓基質細胞以含有香瓜茄發酵汁液處理後,小鼠骨髓基質細胞的UCP2的表現量上升。 From this, it was found that when the mouse bone marrow stromal cells were treated with the fermented juice containing cantaloupe, the expression level of UCP2 in the mouse bone marrow stromal cells increased.
結果如圖9所示,本發明之香瓜茄發酵汁液可提升細胞UCP2的基因表現量,代表,而使香瓜茄發酵汁液對促進脂肪的分解,並使脂肪的累積量降低具有效果。 The results are shown in FIG. 9 , the cantaloupe tomato fermented juice of the present invention can increase the gene expression level of UCP2 in cells, which means that the cantaloupe tomato fermented juice has an effect on promoting the decomposition of fat and reducing the accumulation of fat.
實施例十二:減脂瘦身之人體檢測 Example 12: Human Body Detection for Fat Loss and Slimming
令8位肥胖受試者(即其體脂率大於25%或BMI值大於24)每日飲用一瓶50mL香瓜茄發酵飲料(其含有12vol%例1中所得到的香瓜茄發酵汁液與88vol%水),連續飲用4週。並且,於飲用前(即第0週)及飲用4週後(即第4週),以體重機測量此些受試者體重,以體脂計(廠牌:TANITA BC-601FS)測量此些受試者全身體脂率,以及以布尺量測此些受試者的腰圍。並且,第0週的量測結果與第4週的量測結果之間的統計學顯著差異是藉由學生t-試驗來統計分析,如圖10至圖13所示。在圖10
至圖13中,「*」代表在與第0週比較下其p值小於0.05;「**」代表在與空白組比較下其p值小於0.01。
Make 8 obese subjects (that is, their body fat rate is greater than 25% or BMI value greater than 24) to drink a bottle of 50mL cantaloupe fermented beverage (which contains 12vol% of the cantaloupe and tomato fermented juice obtained in Example 1 and 88vol% water) for 4 consecutive weeks. And, before drinking (ie, the 0th week) and after drinking for 4 weeks (ie, the 4th week), the body weight of these subjects was measured with a body weight machine, and these subjects were measured with a body fat meter (brand: TANITA BC-601FS). The subject's total body fat percentage, and the waist circumference of these subjects was measured with a cloth ruler. Also, the statistically significant differences between the measurements at
參照圖10,相比飲用前(第0週),持續4週飲用香瓜茄發酵飲料可使體重顯著地減少約1.0公斤。 Referring to FIG. 10 , compared to before consumption (week 0), drinking the cantaloupe and eggplant fermented beverage for 4 weeks significantly reduced body weight by about 1.0 kg.
參照圖11,相比飲用前(第0週),持續4週飲用香瓜茄發酵飲料可使全身體脂率顯著地減少約1.0%。 Referring to FIG. 11 , compared to before drinking (week 0), drinking the cantaloupe and eggplant fermented beverage for 4 weeks can significantly reduce the total body fat rate by about 1.0%.
參照圖12,相比飲用前(第0週),持續4週飲用香瓜茄發酵飲料可使軀幹體脂率顯著地減少約1.2%。 Referring to FIG. 12 , compared to before drinking (week 0), drinking the cantaloupe and eggplant fermented beverage for 4 weeks significantly reduced the trunk body fat rate by about 1.2%.
參照圖13,相比飲用前(第0週),持續4週飲用香瓜茄發酵飲料可使腰圍顯著地減少約1.1公分。 Referring to FIG. 13 , compared to before drinking (week 0), drinking cantaloupe and eggplant fermented beverage for 4 weeks can significantly reduce waist circumference by about 1.1 cm.
由此可知,長期使用香瓜茄發酵汁液可改善肥胖者的脂肪累積、體重,即香瓜茄發酵汁液具瘦身減脂之功效。 It can be seen that the long-term use of cantaloupe tomato fermented juice can improve fat accumulation and body weight in obese people, that is, cantaloupe tomato fermented juice has the effect of slimming and reducing fat.
實施例十三:抗氧化之人體檢測 Example 13: Antioxidant human detection
令8位肥胖受試者(即其體脂率大於25%或BMI值大於24)每日飲用一瓶50mL香瓜茄發酵飲料(其含有12vol%例1中所得到的香瓜茄發酵汁液與88vol%水),連續飲用4週。並且,於飲用前(即第0週)及飲用4週後(即第4週)進行採血,並檢測血中的總和抗氧化能力(Total Anti-oxidative Capacity)以及過氧化產物(MDA),其中總和抗氧化能力及過氧化產物是委託立人醫事檢驗所(台灣)進行檢測。 Make 8 obese subjects (that is, their body fat rate is greater than 25% or BMI value greater than 24) to drink a bottle of 50mL cantaloupe fermented beverage (which contains 12vol% of the cantaloupe and tomato fermented juice obtained in Example 1 and 88vol% water) for 4 consecutive weeks. In addition, blood was collected before drinking (ie, the 0th week) and after 4 weeks of drinking (ie, the 4th week), and the total anti-oxidative capacity (Total Anti-oxidative Capacity) and peroxidation products (MDA) in the blood were detected, among which The total antioxidant capacity and peroxidation products were tested by Realan Medical Laboratory (Taiwan).
一般來說,總和抗氧化能力,簡稱為TAC,可代表體內還原氧化物的能力。許多研究顯示自由基會引起人體一些病變,如:心血管疾病及各種發炎疾病等,而體內的抗氧化劑具有保護細胞的作用,可以來防 衛自由基的攻擊,所以,可藉由檢測體內抗氧化能力狀態,來監測身體之失衡狀態,總和抗氧化能力越高,代表體內抗氧化能力越好;過氧化產物(MDA,Malondialdehyde),代表的是體內脂質過氧化的產物,被廣泛接受為氧化損傷的測定標的之一,過氧化產物(MDA,Malondialdehyde)越高,代表體內的氧化壓力越高。 In general, total antioxidant capacity, or TAC for short, represents the ability of the body to reduce oxides. Many studies have shown that free radicals can cause some diseases in the human body, such as: cardiovascular disease and various inflammatory diseases, etc., and antioxidants in the body have the effect of protecting cells and can prevent Therefore, the imbalanced state of the body can be monitored by detecting the state of antioxidant capacity in the body. The higher the total antioxidant capacity, the better the antioxidant capacity in the body; the peroxide product (MDA, Malondialdehyde), representing the Malondialdehyde is the product of lipid peroxidation in the body, and is widely accepted as one of the targets for the determination of oxidative damage. The higher the peroxidation product (MDA, Malondialdehyde), the higher the oxidative stress in the body.
於量測後,將第0週之數值作為基準(即第0週之抗氧化相關數值為100%),計算第4週的相對抗氧化相關數值(%)。並且,第0週的量測結果與第4週的量測結果之間的統計學顯著差異是藉由學生t-試驗來統計分析,如圖14及圖15所示。在圖14及圖15中,「*」代表在與第0週比較下其p值小於0.05;「***」代表在與空白組比較下其p值小於0.001。
After the measurement, the relative antioxidant-related value (%) of the fourth week was calculated by taking the value in the 0th week as the benchmark (ie, the antioxidant-related value in the 0th week was 100%). Also, statistically significant differences between the measurements at
參照圖14,相比飲用前(第0週),持續4週飲用香瓜茄發酵飲料可使總和抗氧化能力顯著地增加約11.0%;其中第0周的總和抗氧化能力原始數值為0.74nmol/L,第4周的總和抗氧化能力原始數值為0.83nmol/L。
Referring to Figure 14, compared with before drinking (week 0), drinking cantaloupe and eggplant fermented beverage for 4 weeks can significantly increase the total antioxidant capacity by about 11.0%; the original value of the total antioxidant capacity in
參照圖15,相比飲用前(第0週),持續4週飲用香瓜茄發酵飲料可使過氧化產物(MDA)顯著地減少約26.1%;其中第0周的MDA原始數值為1.1nmol/ml,第4周的MDA原始數值為0.9nmol/ml。
Referring to Figure 15, compared to before drinking (week 0), drinking cantaloupe and eggplant fermented beverage for 4 weeks can significantly reduce peroxide products (MDA) by about 26.1%; the original value of MDA in
實施例十四:改善肌膚狀況之人體檢測 Example 14: Human testing to improve skin condition
令8位肥胖受試者(即其體脂率大於25%或BMI值大於24)每日飲用一瓶50mL香瓜茄發酵飲料(其含有12vol%例1中所得到的香瓜茄發酵汁液與88vol%水),連續飲用4週。並且,於飲用前(即第0週)及飲用4週後(即第4週),以VISIA肌膚檢測儀(VISIA Complexion Analysis System,購自美國Canfield公司)及皮膚表面濕度測試儀(Corneometer CM825,購自德國C+K公司)檢測肌膚狀況。於此,以VISIA肌膚檢測儀量測肌膚紋理、肌膚皺紋、肌膚泛紅(紅色素),並且以皮膚表面濕度測試儀量測肌膚含水量。 Make 8 obese subjects (that is, their body fat rate is greater than 25% or BMI value greater than 24) to drink a bottle of 50mL cantaloupe fermented beverage (which contains 12vol% of the cantaloupe and tomato fermented juice obtained in Example 1 and 88vol% water) for 4 consecutive weeks. And, before drinking (ie the 0th week) and after drinking for 4 weeks (ie the 4th week), use the VISIA Skin Tester (VISIA Complexion Analysis System, purchased from Canfield Company, USA) and skin surface humidity tester (Corneometer CM825, purchased from C+K Company, Germany) were used to detect skin condition. Here, skin texture, skin wrinkles, and skin redness (red pigment) were measured with a VISIA skin tester, and skin moisture content was measured with a skin surface humidity tester.
於量測後,將第0週之肌膚狀況作為基準(即第0週之相對肌膚狀況為100%),計算第4週的相對肌膚狀況(%)。並且,第0週的相對肌膚狀況與第4週的相對肌膚狀況之間的統計學顯著差異是藉由學生t-試驗來統計分析,如圖16至圖19所示。在圖16至圖19中,「*」代表在與第0週比較下其p值小於0.05。
After the measurement, the skin condition in the 0th week was used as the benchmark (ie, the relative skin condition in the 0th week was 100%), and the relative skin condition (%) in the 4th week was calculated. Also, the statistically significant difference between the relative skin condition at
參照圖16至圖19,相比飲用前(第0週),持續4週飲用香瓜茄發酵飲料可使肌膚紋理顯著地減少約4.3%,使肌膚皺紋減少約5.3%,使肌膚紅色素減少約7.6%,以及使肌膚含水量顯著地增加約9.6%。由此可知,長期使用香瓜茄發酵汁液可改善肌膚狀況,即香瓜茄發酵汁液具改善肌膚狀況之功效。 Referring to Figure 16 to Figure 19, compared to before drinking (week 0), drinking cantaloupe eggplant fermented beverage for 4 weeks can significantly reduce skin texture by about 4.3%, reduce skin wrinkles by about 5.3%, and reduce skin red pigment by about 4.3%. 7.6%, and significantly increased skin moisture content by about 9.6%. It can be seen that the long-term use of the cantaloupe tomato fermented juice can improve the skin condition, that is, the cantaloupe tomato fermented juice has the effect of improving the skin condition.
綜上所述,根據本發明任一實施例的香瓜茄發酵汁液,其可製備改善肌膚狀況及/或減脂的組合物。換言之,前述之組合物具有下列一種或多種功能:提升穀胱甘肽合成、抑制醣化終產物形成、提升抗老相關基因、抑制黑色素生成、提升保濕相關基因分泌、抑制脂肪累積、促進脂肪分解、減少受體的體脂肪以及改善肌膚狀況。 To sum up, according to the fermented juice of cantaloupe tomato according to any embodiment of the present invention, a composition for improving skin condition and/or reducing fat can be prepared. In other words, the aforementioned composition has one or more of the following functions: enhancing glutathione synthesis, inhibiting the formation of glycation end products, enhancing anti-aging-related genes, inhibiting melanin production, enhancing moisturizing-related gene secretion, inhibiting fat accumulation, promoting lipolysis, Reduces body fat in receptors and improves skin condition.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011147988.6A CN114099586B (en) | 2019-08-27 | 2020-10-23 | Application of muskmelon eggplant fermentation juice |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962892081P | 2019-08-27 | 2019-08-27 | |
US62/892,081 | 2019-08-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202108124A TW202108124A (en) | 2021-03-01 |
TWI774046B true TWI774046B (en) | 2022-08-11 |
Family
ID=74733299
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW109129403A TWI757850B (en) | 2019-08-27 | 2020-08-27 | Lactobacillus salivarius tci153 and use of lactobacillus salivarius tci153 and/ or its bacteriolytic solution for preparing compositions that improve skin conditions |
TW109129405A TWI774046B (en) | 2019-08-27 | 2020-08-27 | Use of solanum muricatum fermented liquid for preparing a composition for promoting skin anti-aging ability, promoting anti-glycation ability, reducing melanin content, increasing skin moisturization, reducing skin texture, reducing skin wrinkles, reducing skin redness and/or reducing fat |
TW109129404A TWI749734B (en) | 2019-08-27 | 2020-08-27 | Bacillus coagulans or it’s metabolite and use of bacillus coagulans in preparing compositions for stomach health |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW109129403A TWI757850B (en) | 2019-08-27 | 2020-08-27 | Lactobacillus salivarius tci153 and use of lactobacillus salivarius tci153 and/ or its bacteriolytic solution for preparing compositions that improve skin conditions |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW109129404A TWI749734B (en) | 2019-08-27 | 2020-08-27 | Bacillus coagulans or it’s metabolite and use of bacillus coagulans in preparing compositions for stomach health |
Country Status (2)
Country | Link |
---|---|
CN (3) | CN112442457B (en) |
TW (3) | TWI757850B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114686396A (en) * | 2021-12-23 | 2022-07-01 | 微康益生菌(苏州)股份有限公司 | Helicobacter pylori-resistant bacillus coagulans BC99 and application thereof |
CN114806958B (en) * | 2022-05-10 | 2022-12-09 | 广州维生君生物科技有限公司 | Stomach-derived bacillus coagulans BCF-01 and application thereof |
CN114891699A (en) * | 2022-06-21 | 2022-08-12 | 廖梅香 | Lactobacillus salivarius for regulating flora balance |
KR20240098224A (en) * | 2022-12-20 | 2024-06-28 | 건국대학교 글로컬산학협력단 | Antioxidant, anti-inflammatory and wound healing composition containing Solanum melongena peel extract containing kimchi lactobacillus fermented product |
CN118562689A (en) * | 2024-08-05 | 2024-08-30 | 杭州微致生物科技有限公司 | Helicobacter pylori-resistant Weizhman bacterium coagulans VB320 and application and culture device thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014147199A1 (en) * | 2013-03-20 | 2014-09-25 | Bioatlantis Ltd | A non-nematicidal composition and use thereof |
TW201622736A (en) * | 2014-12-30 | 2016-07-01 | 中山醫學大學 | Use of pepino extract for promoting growth of probiotics |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2378854T3 (en) * | 2008-11-10 | 2012-04-18 | Nestec S.A. | Bacteria that produce sialic acid |
WO2012150269A1 (en) * | 2011-05-03 | 2012-11-08 | Dupont Nutrition Biosciences Aps | Probiotic bacteria for the topical treatment of skin disorders |
CN103932936A (en) * | 2013-01-18 | 2014-07-23 | 湛江市赛美生物科技有限公司 | Ginseng fruit extractives containing specific portion tissue cells and cosmetic composition thereof |
CN103565848B (en) * | 2013-03-19 | 2017-02-08 | 青岛东海药业有限公司 | Application of bacillus coagulans in preparing preparations for preventing and treating helicobacter pylori infection |
TW201717783A (en) * | 2015-08-11 | 2017-06-01 | 嘉康利公司 | Materials and methods for improving gastrointestinal health |
MY182658A (en) * | 2016-01-07 | 2021-01-28 | Sami Labs Ltd | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using bacillus |
PL3634444T3 (en) * | 2017-06-06 | 2024-03-04 | Sami-Sabinsa Group Limited | Compositions for use in the treatment of helicobacter pylori |
CN107519087A (en) * | 2017-08-30 | 2017-12-29 | 上海应用技术大学 | A kind of Solanum muicatum extract and its application in skin moisture-keeping or anti-oxidation efficacy cosmetics |
CN107484935A (en) * | 2017-09-25 | 2017-12-19 | 中国人民武装警察部队工程大学 | A kind of compound lactobacillus-fermencucumber ginseng juice beverage and preparation method thereof |
CN107616985A (en) * | 2017-10-01 | 2018-01-23 | 青岛东海药业有限公司 | Bacillus coagulans preparation and its application |
TWI702055B (en) * | 2018-10-09 | 2020-08-21 | 大江生醫股份有限公司 | Pachyrhizus erosus fermented extracts and the use thereof for enhancing the gene expression of col, timp, lox, eln, has, sod, tcp1 and ung, and for reducing the skin melanin content |
-
2020
- 2020-08-27 TW TW109129403A patent/TWI757850B/en active
- 2020-08-27 TW TW109129405A patent/TWI774046B/en active
- 2020-08-27 TW TW109129404A patent/TWI749734B/en active
- 2020-08-27 CN CN202010880538.1A patent/CN112442457B/en active Active
- 2020-08-27 CN CN202010891724.5A patent/CN112442458B/en active Active
- 2020-10-23 CN CN202011147988.6A patent/CN114099586B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014147199A1 (en) * | 2013-03-20 | 2014-09-25 | Bioatlantis Ltd | A non-nematicidal composition and use thereof |
US20160029627A1 (en) * | 2013-03-20 | 2016-02-04 | Bioatlantis Ltd | A non-nematicidal composition and use thereof |
TW201622736A (en) * | 2014-12-30 | 2016-07-01 | 中山醫學大學 | Use of pepino extract for promoting growth of probiotics |
Non-Patent Citations (1)
Title |
---|
期刊 傅思潔 香瓜茄及以具麩胺酸脫羧酶基因乳酸菌發酵之發酵液其抗氧化、抑制血管收縮素轉換酶能力及體外細胞試驗分析,2012年 國立澎湖科技大學食品科學研究所國立澎湖科技大學食品科學研究所 2012 摘要 * |
Also Published As
Publication number | Publication date |
---|---|
TW202108759A (en) | 2021-03-01 |
TW202108758A (en) | 2021-03-01 |
CN112442457B (en) | 2022-07-22 |
CN112442458B (en) | 2022-07-26 |
CN114099586B (en) | 2023-07-07 |
CN114099586A (en) | 2022-03-01 |
CN112442458A (en) | 2021-03-05 |
CN112442457A (en) | 2021-03-05 |
TWI757850B (en) | 2022-03-11 |
TWI749734B (en) | 2021-12-11 |
TW202108124A (en) | 2021-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI774046B (en) | Use of solanum muricatum fermented liquid for preparing a composition for promoting skin anti-aging ability, promoting anti-glycation ability, reducing melanin content, increasing skin moisturization, reducing skin texture, reducing skin wrinkles, reducing skin redness and/or reducing fat | |
TW202002809A (en) | Fermentation product of Punica granatum and uses thereof | |
TWI784229B (en) | Lonicera japonica thunb ferment, preparation method thereof and use thereof for improving skin appearance and anti-aging | |
JP2023171950A (en) | Anti-aging agent, antioxidant, anti-inflammatory agent, and whitening agent, as well as cosmetic | |
CN114222558A (en) | Methods of inhibiting PAR2 activation and compositions for use in the methods | |
TW202003587A (en) | Use of collagen peptide for inducing expression of CCT gene, Parkin gene and MRPS5 gene, enhancing mitochondrial activity of cells, promoting skin fibroblast proliferation, and anti-aging | |
TWI737086B (en) | Fermentation method for increasing content of effective components in plants | |
TWI729618B (en) | Use of phalaenopsis plant extract for anti-glycation and improving skin appearance | |
TW202110469A (en) | Use of citrus medica var. sarcodactylis fermented liquid for preparing a composition for improving skin condition | |
TWI774168B (en) | Morus alba ferment, manufacturing method thereof and use thereof | |
US20220054398A1 (en) | Use of rubus fruticosus extract for manufacturing a skincare composition | |
TWI789553B (en) | Use of hemerocallis fulva linn. extract for manufacturing of a composition for promoting skeletal muscle basal metaboilc rate | |
TWI809308B (en) | Use of wasabia japonica leaves for inhibiting the production of acne and reducing cutibacterium acnes secretions | |
TWI777096B (en) | Use of extract of ginkgo biloba callus tissue for improving skin redness | |
TWI674107B (en) | Use of imperata cylindrica fermented extract for enhancing the gene expression of keratin, filaggrin and hyaluronan synthase, promoting the proliferation of collagen and elastin, and enhancing antioxidant capacity of skin cells | |
TWI694829B (en) | Use of extract of selaginella tamariscina for inducing expression of keratin gene, hyaluronan synthase gene and filaggrin gene, enhancing mitochondrial activity of cells, enhancing moisture-retaining capacity of skin, and anti-aging | |
TWI687237B (en) | Use of extract of victoria cruziana for inducing expression of keratin gene and hyaluronan synthase 2 gene, and enhancing moisture-retaining capacity of skin | |
JP2021092534A (en) | Method for screening anti-aging component | |
TWI754345B (en) | Use of garcinia mangostana fermented liquid for preparing a composition for beautifying skin and/or reducing fat | |
WO2024008187A1 (en) | Use of prunus lannesiana extract in preparation of drug for improving skin condition or basal metabolic rate | |
TWI734332B (en) | Use of extract of malpighia glabra fruitlet for weight control, skin beauty, anti-inflammation, and anti-aging | |
TWI743393B (en) | Use of extract of rhinacanthus communis callus tissue for promoting collagen production | |
TW202313089A (en) | Use ofhemerocallis fulvalinn. extract in preparing compositions for anti-glycation | |
EP2723358A2 (en) | External preparation for skin |